PMID,Disease
36791022,breast cancer
36791022,mdms
36791022,breast cancer mdms
36790946,cancer deaths
36790946,cancer
36790946,tumor
36790871,glucose metabolism
36790676,glioma
36790676,liver cancer
36790676,tumor metastasis
36790676,liver hepatocellular carcinoma
36790676,carcinoma
36790676,paracancerous
36790676,retards
36790603,lung cancer
36790603,cancer death
36790603,lung adenocarcinoma
36790603,osimertinib and abemaciclib in lung cancer
36790582,leukemia and breast cancer
36790573,oligometastatic breast cancers
36790573,oligometastatic breast cancer
36790573,metachronous metastatic breast cancer
36790573,mbc
36790573,metastases
36790573,visceral metastases
36790533,pigmentation
36790533,dyschromatosis universalis hereditaria
36790533,pigmentary genodermatosis
36790533,hyperpigmented and hypopigmented
36790533,melanoma
36790533,hypopigmented
36790533,hyperpigmentation
36790533,hypopigmentation
36790512,obesity
36790512,breast carcinogenesis
36790512,tumors
36790479,tumoral
36790445,sphingomyelin nanosystems
36790445,tumour
36790360,cha
36790346,tumours
36790346,thyroid neoplasms
36790346,squamous cell carcinoma
36790346,carcinoma of the breast
36790346,renal cell carcinoma
36790346,neuroendocrine carcinoma of the lung
36790346,carcinoma stomach
36790346,malignant melanoma and squamous cell carcinoma
36790346,thyroid carcinoma
36790346,malignancy
36790286,neoplastic lesions
36790286,ductal carcinomas
36790286,carcinogenic
36790070,cancers
36790070,mortality
36790070,malignancies
36790070,pancreatic
36790070,colorectal
36790070,prostate cancer
36790070,malignant melanoma
36790070,non-hodgkin lymphoma
36790070,acute leukemia
36789976,breast lesions
36789760,ovarian cancer
36789760,korean epithelial ovarian cancer
36789760,clc
36789739,invasive cancer
36789739,breast cancers
36789739,i-iii breast cancer
36789739,contralateral breast cancers
36789739,er-negative disease
36789739,er-positive cancers
36789689,colorectal cancer
36789689,malignant tumor
36789689,arrest
36789212,breast abnormality
36789212,breast lesion
36789212,anxiety
36789118,lymphoblastic leukemia
36789118,acute lymphoblastic leukemia
36788982,diabetes
36788982,pancreas and prostate cancer
36788889,crc
36788687,breast adenocarcinoma
36788602,ulcwgs
36788595,breast malignancy before tumor
36788595,breast malignancies
36788595,breast lesion malignancy
36788408,fibrosis
36788408,colorectal cancers
36788408,carcinogenesis
36788310,angiosarcoma xenograft
36788310,angiosarcomas
36788310,angiosarcoma of the breast
36788297,parkinson's disease
36788297,pd
36788297,thyroid cancer
36788297,parkinson disease
36788297,cancer gwass
36788297,pd and ovarian cancer
36788297,movement disorders
36788297,parkinson and movement disorder
36788122,invasive breast cancer
36788122,ductal carcinoma
36788122,benign disease
36788122,invasive ductal carcinoma
36788122,invasive lobular carcinoma
36788122,tnbc
36788100,her2-low breast cancer
36788100,duct carcinoma
36788098,"breast, ovarian, endometrial"
36788098,prostate cancers
36788098,deficiency
36788098,hrd
36788086,her2-low tumors
36788082,sebaceous tumors
36788082,skin adnexal neoplasms
36788082,cutaneous neoplasms
36788082,squamous cell carcinomas
36788082,carcinomas
36788082,skin metastases
36788082,breast or lung cancers
36788081,luminal breast cancer
36788078,tnbc tumors
36788078,tnbc tumor
36788073,endometrial carcinomas
36788073,ovarian tumors
36788073,ovarian and endometrial tumors
36788073,thyroid tumors
36788073,serous carcinoma
36788073,clear cell carcinoma
36788073,endometrioid carcinoma
36788073,mucinous carcinoma
36788073,sex cord stromal tumors
36788073,ovarian nonmucinous carcinomas and endometrial carcinomas
36788073,ovarian germ cell tumors
36787951,fascial plane block
36787951,unilateral breast cancer
36787951,toxicity
36787933,vulvar cancer
36787933,squamous cell vulvar cancer
36787921,coronavirus disease 19
36787921,covid-19
36787921,systemic lupus erythematosus
36787921,sle
36787921,sle disease
36787754,lymphadenopathy
36787754,breast tumor
36787754,pain
36787754,siliconomas
36787754,node siliconomas
36787669,breast lesion segmentation
36787617,luminal breast cancers
36787613,tardia
36787512,ovarian
36787512,breast and ovarian cancer
36787508,toxicities
36787313,depression
36787313,depressive disorder
36787313,depressive
36787313,inflammation
36787313,neurotoxicity
36787313,dysregulated hypothalamic-pituitary-adrenal axis
36787313,inflammation-related depression
36787313,breast carcinoma
36787313,organic illness
36787313,psychiatric
36786946,invasive neoplasms
36786674,osteolytic metastases
36786674,h-rise
36786674,pbs
36786674,cytotoxicity
36786671,deep inspiration breath hold
36786671,right breast cancer
36786671,cardiac substructures
36786671,left breast cancer
36786671,mhd
36786551,mtnbc
36786551,type of breast cancer
36786196,breast or lung cancer
36786196,overdose
36786196,overdosing
36786171,death
36786171,coronavirus disease 2019
36785738,metastasis
36785738,cold shock
36785738,tumor spheroid
36785707,clear cell renal cell carcinoma
36785707,kidney cancer
36785645,willingness
36785645,breast and cervical cancers
36785645,-cancers
36785489,"ovarian, tubal and peritoneal cancers"
36785489,invasive epithelial cancers
36785489,familial cancer
36782375,bca tumours
36782375,kaohsiung veterans
36782224,bc carcinogenesis
36781911,reflux esophagitis
36781911,cardiovascular disease
36781911,sleep disturbance
36781911,gastro-esophageal reflux disease
36781911,gerd
36781869,aggressive tumors
36781846,catastrophic injury
36781846,hu toxicity
36781846,tumor cell death
36781754,hyperthermia
36781707,cardiotoxicity
36781707,qtc prolongation
36781707,cardiotoxic
36781543,stress
36781474,necrotic
36781238,typecarcinoma
36781238,invasive micropapillary carcinoma
36781238,invasive papillary carcinoma
36781223,ductal carcinoma in situ
36781219,aggressiveness
36781026,retinopathy
36781026,retinal/choroidal toxicity
36781026,tam retinopathy
36781026,retinal toxicity
36780963,cmd
36780800,tumor immune dysfunction
36780734,febrile neutropenia
36780734,gastrointestinal cancer
36780734,lymphoma
36780734,neutropenia
36780734,lymphoid hemopathy
36780624,in breast cancer
36780614,malignant breast lesions
36780614,hyperplasia
36780614,lobular carcinoma
36780531,brain metastases
36780531,brain neoplasm
36780531,melanoma bmics
36780531,melanoma premetastatic bmics
36780467,congress and breast cancer congress
36780460,antonio breast cancer symposium
36780426,low toxicity
36780270,mitochondria-targeted piezodynamic cancer
36780234,cancerous
36780214,developmental disabilities
36780214,idd
36780214,idds
36780065,breast tumours
36780065,cardiotoxicities
36780065,hd
36779982,invasive malignancy
36779982,leukemia/lymphoma
36779961,neck cancer
36779863,hypertension
36779863,pulmonary diseases
36779309,breast cancer os
36779121,breast reduction or mastopexy
36779121,bilateral breast reduction or mastopexy
36779121,invasive tumours
36779118,malignant gastrointestinal stromal tumor
36779118,primary breast cancer
36779118,gastrointestinal stromal tumors
36779118,mesenchymal tumors
36779118,epithelial tumors
36779118,gastrointestinal stromal tumor
36779118,primary cancers
36779118,axillary lymphadenopathy
36779118,axillary metastases
36779038,dm
36778984,spinal tumors
36778795,postoperative pain
36778795,nausea
36778795,vomiting
36778795,nausea vomiting
36778735,cognitive decline in breast cancer
36778735,cognition impairment
36778735,cognition impairment of the breast cancer
36778653,pseudoangiomatous stromal hyperplasia
36778653,oval hypoechoic mass
36778653,fibroadenoma
36778653,angiosarcoma
36778652,invasive ductal cancers
36778385,joint pain
36778343,breast tumors
36778343,tumor-macrophage
36778271,hypoxia
36778256,breast cancer metastases
36778247,dependencies of cancer
36778229,pruritic
36778229,inflammatory skin disease
36778229,pn skin
36778229,pn lesional skin
36778229,pn lesional fbs
36778229,renal sclerosis
36778229,idiopathic pulmonary fibrosis
36778229,atopic dermatitis
36778229,ad
36778229,psoriasis
36777514,epithelial tumor
36777514,immunodeficient
36777506,breast lymphoma
36777506,primary breast lymphoma
36777506,b-cell lymphoma
36777506,extranodal lymphoma
36777502,ovcar-3 ovarian cancer
36777384,ii breast cancer
36777384,dermatitis
36777384,contracture
36777230,fatigue
36777230,breast and lung cancer
36777188,negative-breast cancer
36776843,sphingolipid metabolism
36776716,hereditary diffuse gastric cancer
36776716,gastric cancer
36776716,lobular type breast cancer
36776716,epithelial neoplasms
36776716,hereditary gastric cancer
36776716,colorectal polyp
36776716,adenoma
36776716,sessile serrated lesion
36776716,polyps
36776716,colorectal polyps
36776368,aggressiveness of tnbc
36776335,cardiorespiratory fitness
36776335,deficits
36776297,epithelial ovarian cancer
36776297,late-stage disease
36776291,cancer influence breast and colorectal cancer
36775838,pancreatic cancer
36775838,hepatotoxicity
36775838,colon cancer
36761830,cervical cancers
36761830,oral squamous cell carcinoma
36761830,oral cancers
36775656,deaths
36775648,weight loss
36775449,colonic
36775354,neck squamous cell carcinoma
36775354,bladder cancer
36775354,pd-1/pd-l1 blockade
36775354,neck squamous and bladder cancers
36775354,bladder cancers
36775354,non-small cell lung cancer
36775354,nsclc
36775350,low breast cancer
36775221,eps
36775221,hemolysis
36775221,cancerous cell death
36775066,metastasis of breast cancer
36774875,hdf
36774758,breast and lung cancers
36774756,ebc
36774386,aneuploidy
36774357,malignant breast tumors
36774339,breast cancer malignancy
36773804,metabolites of prostate cancer
36773796,neurodegenerative diseases
36773796,lysosomal storage disorders
36773567,bladder urothelial carcinoma
36773567,breast invasive carcinoma
36773567,lung squamous cell carcinoma
36773567,colon adenocarcinoma
36773567,prostate adenocarcinoma
36773567,skin cutaneous melanoma
36773567,pancreatic adenocarcinoma
36773567,rectum adenocarcinoma
36773567,stomach adenocarcinoma
36773567,lihc
36773531,invasive ductal carcinomas
36773531,luminal type cancers
36773531,high apt sis
36773404,li-fraumeni syndrome
36773404,li fraumeni syndrome
36773404,lfs
36773404,hereditary cancer
36773184,cancer mortality
36773123,attachment anxiety
36773021,cognitive impairment
36773021,cognitive decline
36772982,catalonia
36772982,cataract
36772966,triple-negative breast cancer
36772966,erbeta+tnbc
36772945,cancer tumor
36772945,cafs across cancers
36772932,breast and endometrial cancer
36772881,qt prolongation
36772881,qtcspl
36772881,qtcf
36772881,qtcspl to address hr
36772804,colon
36772804,glioblastoma
36772592,tcia breast cancer
36772536,metastasized alns
36772091,breast cancer hyperthermia
36771391,hepatocellular carcinoma
36771385,adenocarcinoma-dominant cancers
36771385,leukemia
36771385,breast and prostate cancer
36771385,bowel cancer
36771385,gastrointestinal adenocarcinomas
36771239,headaches
36771126,novel prostate cancer
36771126,cardiovascular disorders
36771126,hypercholesterolemic
36771126,breast and prostate cancers
36771126,ccd
36771106,hepatic tumour
36771032,se
36771032,obesity-related diseases
36771032,hepatoma
36771032,leukemia cancers
36770951,es-2 ovarian and a-549 lung adenocarcinomas
36770864,casearia coriacea vent
36770864,leishmania mexicana mexicana and trypanosoma brucei brucei
36770864,malaria parasite
36770864,pulmonary adenocarcinoma
36770864,pancreatic carcinoma
36770830,hyperthermophile archaeoglobus fulgidus ferritin
36770781,stemness of breast cancer
36770518,cytotoxicity of carbon nanotubes
36770518,cardiovascular diseases
36770518,mcf-7 breast cancer
36770357,various diseases
36769814,paralysis
36769814,metastatic epidural spinal cord compression
36769814,fracture
36769814,fractures
36769814,spinal metastases
36769814,spinal injury
36769814,sensorimotor impairments
36769814,spinal instability neoplastic
36769814,neurologic impairments
36769602,tnbc fits
36769509,rotation compensation
36769280,luminal breast cancer mcf-7
36769280,breast cancer cell malignancy
36769274,colorectal and liver neoplasms
36769274,colorectal and liver cancers
36769251,metastasis in breast cancer
36769251,liver metastasis
36769251,lung metastases
36769251,liver metastases
36769210,aids
36769210,infection
36769210,breast to leukemia
36769184,ductal breast cancer
36769184,mastopathy
36769184,stroma of breast cancer
36769177,cancer diseases
36769177,carcinogenesis of human breast cancer
36769125,aggressiveness of breast cancer
36769125,aggressiveness of cslc
36769029,metabolic diseases
36769029,type 2 diabetes
36769029,breast and colon cancer
36769029,inflammatory diseases
36768939,neoplasm
36768939,malignancy of tumors
36768939,malignant cmts
36768923,actual tumor
36768923,glioblastoma multiforme
36768838,luminal versus basal breast cancer
36768838,basal breast cancers
36768815,increase tumor aggressiveness
36768694,apoptosis of ovarian
36768694,colorectal and ovarian cancer
36768694,aml
36768694,cholangiocarcinoma
36768694,pancreatic ductal adenocarcinoma
36768694,brain tumour cancer
36768647,rupture
36768623,endometrial cancer
36768623,vaginal small cell carcinoma
36768568,human ovarian carcinoma
36768568,lung carcinoma
36768478,solid tumors
36768427,sphingolipid metabolism in breast cancer
36768427,sphingolipid metabolites
36768363,deltapsim
36768191,breast carcinomas
36767461,analgesia nociception
36767073,dry mouth
36767056,traumatic stress
36766992,breast cancer tumor
36766992,progressive disease
36766896,polycystic ovary syndrome
36766896,pcos
36766896,diabetics
36766893,papillomavirus (hpv) infection
36766786,aggressive breast cancer
36766734,epidermoid carcinoma
36766734,necrotic cell death
36766681,skin cancer
36766645,benign breast lesions
36766641,enthusiasm
36766641,tedious breast cancer
36766575,tumor aggressiveness
36766541,classifying breast cancer metastasis
36766517,cad
36766517,brightness error
36766486,tnbc lesions
36766484,pelvic lesions
36766484,ovarian tumours
36766484,carcinomatosis
36766484,breast carcinoma metastasis
36766484,ovarian/peritoneal carcinoma
36766484,metastasis of lymphoma
36766484,endometrial carcinoma
36766484,malignant lesions
36766484,peritoneal carcinomatosis or ovarian carcinoma
36766472,bone lesions
36766472,breast tumor lesions
36766453,learning algorithms
36765925,tumor necrosis
36765923,pancreatobiliary cancers
36765923,pancreaticobiliary cancers
36765921,malignancy of breast lesions
36765876,infections
36765870,tumour growth models of breast cancer
36765870,invasive cancers
36765853,hr+ breast cancer
36765851,aggressive breast cancers
36765839,histopathological breast cancer
36765831,cognitive symptoms
36765776,primary high-grade advanced ovarian cancer
36765776,tumor hrd
36765776,insufficient tumor
36765720,her2-positive breast cancer
36765717,pancreatic and breast cancer
36765715,tics
36765715,ovarian cancers
36765709,cancer toxicities
36765699,non-breast cancer
36765667,iv epithelial ovarian cancer
36765667,iva
36765667,pleural effusion
36765667,pleural involvement
36765666,ovarian and breast cancer
36765651,metastatic breast cancer
36765651,bone disease
36765650,breast disorders
36765648,myelotoxic
36765642,breast cancer disease
36765642,svd
36765631,lymphedema in breast cancer
36765631,breast cancer-related lymphedema
36765631,inflammatory disorder
36765602,chronic lymphocytic leukemia
36765602,t cell lymphomas
36765602,head and neck cancers
36765602,lymphocytic leukemia
36765598,dementia
36765598,dementia increases
36765598,head and neck cancer
36765598,brain tumor
36765592,breast cancer lymph node metastasis
36765571,radiation dermatitis
36765538,sarcoma
36765538,sarcomas
36765538,breast and gastrointestinal cancers
36765538,renal disease
36765538,bone sarcomas
36765535,tumor initiation
36765529,osteotropic
36765529,bone metastases
36765527,disseminated tumor
36765432,hereditary cancers
36765432,"endometrial, ovarian, colorectal"
36765432,fhht
36765430,adenocarcinoma
36765430,carcinoma ts
36765430,beta-galactosidase
36765409,skin malignancy
36765409,angiomirs
36765408,ovary
36765408,leukaemia
36765408,bladder
36765397,hr+her2-breast cancer
36765275,endocrine resistant breast cancer
36765265,swelling
36765154,adverse cardiovascular and cerebrovascular events
36765154,adverse cardiovascular and cerebrovascular
36765154,acute myocardial infarction
36765154,ischemic stroke
36765154,stroke
36764880,iv disease
36764879,invasive breast cancers
36764873,bc tumors
36764734,dystrophic calcification
36764493,liver cscs
36764447,hypopituitarism
36764447,visual field deficits
36764231,cell growth arrest
36764231,sar
36764019,lymphedema
36764019,upper extremity dysfunction
36763623,breast malignancy
36763552,vestibular schwannomas
36763359,dyspareunia
36763188,myelosuppression
36763188,gs
36763051,artery occlusion
36763051,hypoxic
36763051,retinal vein occlusion
36763051,retinal artery occlusion
36763051,diabetic retinopathy
36763051,stroke-type condition
36763051,blindness
36763051,retinal ischemia
36763051,rabbit eyes
36763051,ischemic
36763035,fitness
36762843,lobular breast cancer
36762832,chemotoxicity
36762832,group-breast cancer
36762811,meningioma
36762811,host tumor
36762811,peritumoral brain edema
36762811,metastasis of invasive ductal carcinoma
36762811,intra-meningioma metastasis
36762803,infertile central nervous
36762783,inflammatory breast cancer
36762782,hrqol
36762781,pdx tumors
36762663,seroma
36762416,hepatoxicity
36762368,endometriosis pathology and pain
36762368,endometriosis
36762368,infertility
36762368,endometriosis lesions
36762368,lower ovarian
36762368,premature ovarian insufficiency
36762368,pelvic pain
36762368,whereby endometriosis
36762329,hrplus
36762329,herplus
36761973,2019 global burden of disease
36761973,apc
36761969,rural cancer
36761968,brain metastasis
36761757,hematological malignancies
36761757,hostile tumor
36761757,cars
36761757,tumor toxicities
36761753,hallmark of tumors
36761429,endometrial clear cell carcinoma
36761429,endometrial serous carcinoma
36761373,solid-papillary carcinoma
36761373,papillary breast carcinomas
36761373,invasive solid-papillary carcinoma
36761373,multifocal ductal carcinoma
36760835,disease-like breast cancer
36760569,cardiovascular (cv) death
36760569,traumatic psychological stress
36760569,cv death
36760569,outweighs cancer death
36760569,cv deaths
36760343,glioma in colombia
36760343,hypofractionation of prostate
36760254,chemoresistant tumors
36760158,hematological toxicity
36760158,vitiligo
36760158,upper back
36760012,multidisciplinary breast cancer
36759982,alpelisib
36759846,benign breast diseases
36759846,breast benign disease
36759786,malignancy in breast cancer
36759786,necrosis
36759733,colorectal tumors
36759723,tumour initiation
36759673,common t-vec toxicities
36759673,fevers
36759673,headache
36759673,thromboembolic
36759573,neuroblastoma and breast cancer
36759253,wa cancer
36759216,died
36759122,dyspnea
36759122,atrial fibrillation
36759122,coronary artery disease
36759122,hemoptysis
36759039,adenoid cystic carcinoma
36759039,lobular breast carcinomas
36758843,malignant tumors
36758833,cytotoxicity of car-t
36758833,tumor malignancies
36758833,liver cancers
36758833,prostate cancer tumor
36758833,prostate tumor
36758833,tumor spheroid cytotoxicity
36758499,hrd positive cancers
36758499,ovairan cancer hrd
36758499,brca-deficient breast cancer
36758448,lymphangiosis carcinomatosa
36758448,heart disease
36758326,learning for breast cancer classification
36758326,cancer malignancy
36758146,mg glioblastoma
36758048,sporadic breast cancer
36758048,obese
36757913,drug-resistant triple negative breast cancer
36757913,cmc
36757913,ha-ss-cmc
36757913,emulsification
36757913,drug aggregation
36757900,salpingo-oophorectomy reduces breast and ovarian cancer
36757899,49 citrullinated proteins
36757813,epithelial cancers
36757707,leptomeningeal disease
36757500,infectious diseases
36757500,colorectal carcinoma
36757500,tumor boards
36757500,autoimmunity
36757498,sexual dysfunction and sexual distress
36757498,sexual dysfunction
36757498,sexual distress
36757498,sexual distress in bcss
36757143,hypoxia-promoting mesenchymal tnbc
36757139,hr-negative breast cancer
36757139,invasive tumors
36757135,brca tumor
36757106,ndds
36757050,esophageal squamous cell carcinoma
36757050,tumor stemness
36756934,osteogenesis
36756934,bone defects
36756934,trauma or tumor
36756934,osteogenesis of infected bone defects
36756934,osteogenic
36756934,craniofacial bone defects
36756852,slovenia
36756852,malignant neoplasm
36756852,bc deaths
36756852,premature death
36756721,iridoid glucosides
36756380,endometrial carcinoma across europe
36756380,johnson
36756142,abemaciclib plus endocrine
36756142,idfs
36756000,leptomeningeal carcinomatosis
36756000,pia and arachnoid matter
36756000,urinary incontinence
36755926,metabolic abnormality
36755926,obesity-related endocrine cancers
36755860,benign breast tumours
36755860,breast cancer tumour
36755606,tumour glycolysis and tumour
36755606,til deficiency
36755606,tumour stroma
36755503,peripheral neuropathy
36755503,neuropathy
36755503,motor neuropathy
36755294,lynch syndrome
36755294,oligometastatic disease
36755294,systemic disease
36755288,mitochondrial dysfunction
36755280,grss
36755259,stroma
36755067,cell death
36755067,proteotoxic stress
36754982,mesothelioma
36754982,melanoma and renal cell carcinoma
36754982,hematopoietic malignancies
36754982,colon tumor
36754936,residual disease
36754246,cancer pain
36754246,hypersensitivity
36754246,perineural breast cancer
36754246,mechanical hypersensitivity
36754037,gastrointestinal carcinomas
36753992,melanoma of skin and cancers
36753991,endocrine symptoms
36753973,arsenic poisoning
36753965,hepatic malignancies
36753957,mipd
36753759,icd
36753759,tumor cell necrosis
36753690,breast and hematological cancers
36753620,tumor hypoxia
36753274,financial toxicity
36753200,colombia 2014
36753199,lower limb fatigue
36753162,type ii damage
36753162,cardiac insufficiency
36753162,heart failure
36753153,dyadic perception
36753153,breast tumors of the national cancer
36753003,respiratory depression
36753003,neuropathic pain
36752886,hypnotic
36752886,mood disorders
36752886,neurodegenerative disorders
36752860,neoplasia
36752860,hyperplasia/lobular carcinoma
36752860,flat epithelial atypia
36752780,dysfunctional
36752780,malignant tumours
36752516,venous thromboembolism
36752516,flap loss
36752508,colorectal and lung cancers
36752508,colorectal and lung cancer
36752370,ductal carcinoma in situ to invasive cancer
36752370,dcis lesions
36752370,invasive disease
36752251,posttraumatic stress
36752251,posttraumatic stress disorder
36752251,ptsd
36752251,trauma
36752251,osijek
36752251,ptsd symptoms
36751827,oral cancer
36751724,chemo-hyperthermia of cancer
36751724,pps-mnps
36751336,chronic pain
36751235,stress in breast cancer
36751235,iii breast cancer
36750321,fa deficiency
36750321,dysregulation of fa metabolism
26389234,male breast cancer
36749874,non-luminal breast cancer
36749630,trim21 deficiency
36749630,colorectal and breast cancers
36749493,occult tumor
36749493,paget's disease
36749415,colorectal and prostate tumors
36749410,periodontitis and breast cancer
36749410,periodontitis
36749410,periodontitis on breast cancer
36749328,loss of ovarian
36749328,vasomotor symptoms
36749312,multidisciplinary cancer
36749312,"melanoma, breast cancer"
36749285,familial breast cancers
36749057,pink oyster mushroom pleurotus djamor
36748905,covid
36748905,non-cancer
36748905,sars-cov-2 infection
36748905,covid19-related
36748905,myalgias
36748905,gastrointestinal symptoms
36748905,cough
36748905,lymphocytopenia
36748905,myalgia
36748820,acute myeloid leukemia
36748676,papillary carcinoma
36748676,solid papillary carcinoma
36748676,neuroendocrine tumor
36748676,invasive carcinoma
36748659,ovarian and testicular cancer
36748659,brain tumors
36748334,inherited cancer syndromes
36748334,breast/ovarian cancer
36748210,fits
36748142,breast micropapillary ductal carcinoma
36748136,breast fibroepithelial tumors
36748136,fibroepithelial tumors
36747860,tmas
36747801,static carcinoma
36747801,cryptic lamellipodiamyosin vi
36747772,tumor metastases
36747772,stemness
36747762,silenced tumor
36747279,pgs
36747232,nephrology
36747213,appetite loss
36747141,covid-19 pneumonia
36746967,biliary tract cancers
36746967,solid tumours
36746967,diarrhoea
36746899,loss of consciousness
36746877,dysbiosis
36746877,osteoporosis
36746877,endometrial hyperplasia
36746877,cardiometabolic diseases
36746877,type 1 endometrial hyperplasia
36746877,gingival inflammation
36746877,menopausal periodontitis
36746877,blood glucose
36746720,invasive bc
36746720,peritumoural-tumour
36746578,photo-chemotoxicity
36746533,genotoxic stress
36746533,gouty arthritis
36746533,alzheimer disease
36746533,lung cancers
36746463,pancreatic lesions
36746463,hereditary breast and ovarian cancer syndrome
36746463,papillary mucinous neoplasms
36746463,pancreatic neoplasm
36746049,type i aie photosensitiser
36745996,basal cell carcinoma
36745996,bcc carcinoma
36745996,skin carcinomas
36745503,rcc
36745503,hematological cancers
36745223,melanoma growth
36745138,hyperuricemia
36745138,gout
36745138,metabolic syndrome
36745138,chronic kidney disease
36745138,rheumatism
36745138,atrophy
36744961,reovirus infection
36744734,breast cancer tumors
36744734,rigidity
36744734,slowing breast cancer
36744691,breast carcinoma mcf7 and hepatocellular carcinoma
36744446,fatigued
36744446,fatigue and depression
36744396,papillary thyroid carcinoma
36744179,hulc
36744161,paired hepatocellular carcinoma
36744056,rash
36744056,eczema
36743520,constipation
36743185,hhus
36743146,radiodermatitis in breast cancer
36743146,radiodermatitis
36742386,endometrial cancers
36742232,"2019, invasive ductal carcinoma"
36742068,hyperlipidemia
36741731,mesenchymal neoplasms
36741731,bone sarcoma
36741731,stromal tumor
36741731,breast sarcoma
36741704,growth arrest
36741704,rb deficient
36741701,palliative craniocerebral
36741517,breast cscs than bulk breast cancer
36741517,breast csc death
36741448,bile
36741380,field of ovarian cancer
36741314,intestinal tumors
36741314,mucinous adenocarcinoma
36741314,ngs
36741314,cup tumors
36741258,solid tumor
36741254,breast-cancer
36741020,aapc
36741020,premature deaths
36741020,gastrointestinal cancers
36741020,colon and rectum cancer
36741011,giant breast leiomyoma
36741011,breast leiomyoma
36741011,benign tumor
36741011,leiomyoma
36741008,toxicity in breast cancer
36741008,skin toxicity
36740817,rhabdomyolysis
36740512,rfs
36740198,hdgc
36740198,dominantly-inherited cancer syndrome
36740198,lbc
36740148,necroptotic death
36740148,breast carcinoma t-47d
36740148,necroptosis in breast carcinoma
36739952,malignant neoplasms
36739952,malignant neoplastic myoepithelial
36739952,tubular adenoma
36739952,adenomyoepithelioma and adenoid cystic carcinoma
36739952,hidradenoma
36739952,spiradenoma
36739952,pleomorphic adenoma
36739952,benign breast neoplasms
36739952,adenomas
36739952,pleomorphic adenomas
36739952,benign salivary gland tumors
36739824,multiple breast cancer
36739824,autosomal dominant inherited cancer
36739824,adrenocortical carcinomas
36739824,leukemias
36739630,musculoskeletal pathologies
36739629,breast cancer-related lymphoedema
36739629,oedema
36739629,lymphoedema
36739605,cold tumors
36739605,acidic tumor
36739605,adverse toxicities
36739475,invasive cribriform carcinoma
36739475,very rare disease
36739475,painful
36739475,icc breast cancer
36739462,carcinoma metastasis
36739462,metastasis tumour
36739462,lymph node tumours
36739414,immunogenic breast tumors
36739399,bone loss
36739399,periodontal disease
36739285,ovarian suppression
36739227,breast cancers versus screen detected breast cancers
36739227,interval breast cancer
36739227,interval cancers
36739077,hypoxic cancer
36739077,diabetic
36739077,cancer stemness
36739077,hypoxic breast cancer
36739077,breast cancer stemness
36738577,aggressive cancers
36738577,loss of anchorage
36738577,metastasis of aggressive cancers
36738520,auc rise
36738497,death of cholangiocarcinoma via akt
36738368,idiosyncratic adverse drug reactions
36738358,multidimensional fatigue
36738118,malignancies of breast
36738118,malignant nme lesions
36737859,chronic diseases
36737820,mucinous cystadenocarcinoma
36737800,scad
36737799,muscle-invasive bladder cancer
36737799,muscle-invasive bladder cancers
36737799,multiple cancers
36737799,bladder tumor
36737799,lv
36737799,luminal tumors
36737789,tumoroids which recapitulate the tumor
36737760,-breast cancer
36737658,drrd
36737644,cls
36737552,advanced epithelial ovarian cancer
36737552,pds
36737530,pwb-chest
36737428,breast cancer liver metastasis
36737303,asthenia
36737303,anorexia-cachexia syndrome
36737248,tma
36737116,mods
36737094,bowel and prostate cancer
36737094,"breast, bowel or prostate cancer"
36736967,low cytotoxicity
36736967,mcf-7 cancer
36736951,lymphatic dysfunction
36736951,autoimmune complications
36736951,unilateral breast cancer-related lymphedema
36736951,lymphedematous
36736908,immunogenic cell death
36736725,breast and colorectal cancer
36736725,coaching sessions
36736632,cardiac events
36736631,invasive breast (bc) cancer
36736548,rcds
36736548,hydrophilic lrcds
36736488,ovarian serous cystadenocarcinoma
36736144,ovarian and breast cancers
36736144,"breast, ovarian, fallopian tube"
36735704,lower breast cancer
36735254,congestive heart failure
36735254,chf
36735117,facial flushing and swelling
36735117,gingival hemorrhage
36735117,telangiectasia
36735117,luminal b breast cancer
36735048,high tils
36735048,her2-enriched breast cancers
36735048,her2-enriched cancers
36735048,luminal cancers
36734949,hepatic cancer
36734949,renal cell cancer
36734949,colon oral
36734949,head cancer
36734872,advanced disease
36734872,renal hypertension
36734848,thoracoabdominal metastases
36734527,diarrhea
36734527,crf
36734379,meningiomas
36734379,tumour-to-meningioma metastasis
36734379,systemic cancers
36734379,parasagittal tumours
36734379,meningioma metastasis
36734379,focal deficits
36734379,seizures
36734379,cranial nerve palsies
36734308,dmfs
36734308,dfs
36734288,multicentric breast cancer
36734288,mc breast cancers
36734288,mf/mc breast cancers
36734288,mc breast tumors
36734184,sk-ov-3 ovarian cancer
36734154,hypothetical breast cancer
36734154,enthusiasm for cancer
36733936,disseminated cancers
36733936,osteoblastic
36733936,sclerotic bone metastases
36733936,osteosarcoma
36733936,multiple myeloma
36733936,cancer metastases
36733863,fare-sf-p
36733797,isthmic papillary thyroid carcinoma
36733797,aggressive thyroid cancer
36733797,isolated papillary thyroid carcinoma
36733797,chronic lymphocytic thyroiditis
36733442,pressures
36733182,meningeal carcinomatosis of gastric cancer
36733182,meningeal carcinomatosis
36733182,gastric cancer metastasis
36733163,invasive ductal carcinoma of the breast
36733163,skin defect
36733162,drug-induced interstitial pneumonia
36733162,shortness of breath
36733162,cardiac dysfunction
36733162,interstitial pneumonia
36733162,pneumonia
36733155,metachronous gastric cancer
36733155,inflammatory gastric mucosal lesion
36733151,abdominal pain
36733127,sinus metastasis
36733127,postoperative maxillary gingival carcinoma
36733127,gingival squamous cell carcinoma
36733127,orbital pain
36733127,failing vision
36733127,movement disorder
36733127,gingival carcinoma
36733127,multiple organ failure
36733124,bleeding
36733124,ulceration
36733113,gastric gist liver metastasis
36733113,cystic lesion
36733113,malignant disease
36733113,hepatic cystadenocarcinoma
36733113,liver metastasis of gastric gist
36733112,multiple bone metastasis
36733112,severe pain
36733112,left cystic breast tumor
36733112,costal bone lesion
36733112,painful bone lesions
36733112,letrozole plus palbociclib
36733092,postoperative lymph node metastasis
36733092,anterior pancreatic lymph
36733092,middle thoracic esophageal cancer
36733083,massive lymphadenopathy
36733051,pneumocystis jirovecii pneumonia
36733051,fever
36733049,upper limb edema
36733048,srs
36733048,brain tumor lesion
36733034,breast metastasis
36733034,right renal cell carcinoma
36733034,metastases of renal cell carcinoma
36733034,metastatic renal cell carcinoma
36733033,hyponatremia
36733033,tonic-clonic seizure
36733033,vertigo
36733033,postoperative nausea
36733033,delirium
36733033,seizure
36733033,hyponatremic tonic-clonic seizure
36733032,cardiac tamponade
36733032,cancerous pericarditis
36733032,liver
36733032,pericardial effusion
36733032,respiratory distress
36733032,trastuzumab plus pertuzumab
36733016,non-colorectal liver metastases
36733016,colorectal liver metastasis
36733016,renal cancer
36733016,acinic cell carcinoma
36733016,leiomyosarcoma
36733016,neuroendocrine tumors
36732999,intestinal obstruction
36732999,colon stenosis
36732999,colorectal cancer metastases
36732988,skin invasion
36732988,anemia
36732988,breast cancer skin invasion
36732987,breast nodular fasciitis
36732987,nodular fasciitis
36732562,breast cancer death
36732462,glycosidic
36732183,iatrogenic tumor
36731945,spontaneous rupture
36731945,oligometastatic hepatic melanoma
36731945,pulmonary metastases
36731945,venous bleeding without active arterial bleeding
36731945,hepatic artery branches
36731945,spontaneous rupture of solitary liver metastases
36731891,brca1 deficiency
36731891,memory tumor
36731833,pulmonary arteriovenous
36731732,hyperthermia ability
36731722,pulmonary hypertension
36731722,ventricular pressure
36731722,endothelial dysfunction
36731722,cardiac hypertrophy
36731722,attenuated pulmonary hypertension
36731601,hela cancer
36731462,brcaness
36731351,tiredness
36731274,metastasized tumors
36730548,polyneuropathy
36730498,breast deformities
36730498,hematoma
36730498,skin flap necrosis
36730498,ptosis
36730488,latissimus dorsi flap
36730467,b-cell acute lymphoblastic leukemia
36730339,adjuvant t-dm1 versus trastuzumab for residual invasive disease
36730303,liver metastasis of her2-positive breast cancer
36730303,multiple liver metastases
36730303,liver metastasis lesions
36730303,liver lesions
36730296,thrombocytopenia
36729942,paravertebral block
36729554,narcotic pain
36729438,hodgkin lymphoma
36729413,necrosis and flap failure
36729413,flap failure
36729355,breast cancer initiation
36729271,gastric cancers
36729271,neuroendocrine carcinoma
36729271,adenoneuroendocrine carcinoma
36729248,hereditary breast cancers
36729248,bn tumors
36729189,ductal carcinoma in situ or microinvasive carcinoma
36729147,nk/t-cell lymphoma
36729147,hemophagocytic syndrome
36729099,tumor stasis
36729073,musculoskeletal symptoms
36729055,remodeling tumor
36729055,death of tumor
36728825,irritability
36728788,breast-cancer related lymphedema
36728788,unilateral upper extremity lymphedema
36728476,venous thromboembolism chemoprophylaxis
36728476,vte
36728380,breast neoplasm
36728202,anaplastic large cell lymphoma
36728181,depressive mood
36728181,cognitive dysfunction
36728181,classification of diseases cancer
36728172,weight gain
36728146,prostatic cancer
36728144,low back pain
36728139,hepatitis
36728139,invasive lobular breast carcinoma
36728139,photopenia
36727812,hypoechoic lesions
36727812,lactational hyperplasia
36727774,situ tumor
36727752,decreases breast cancer
36727752,increases breast cancer
36727729,breast cancer related lymphedema
36727613,malignant behaviors of breast cancer
36727543,melanoma skin cancer
36727117,breast metastases
36727116,brachial plexopathy
36727116,malignant peripheral nerve sheath tumor
36727116,malignant peripheral nerve sheath tumors
36727074,cardiac toxicities
36727074,lad
36727057,tumour-suppressive
36727044,ductal carcinoma in-situ
36727017,myelotoxic febrile neutropenia
36727017,cin
36727017,myelotoxicity
36726946,ascites
36726946,pseudomyxoma peritonei
36726946,blood ascites
36726635,gbd
36726381,hpa
36726376,mfs
36726293,osteoclastic
36726293,breast cancer bone metastasis
36726293,osteolytic lesions
36726152,cachexia
36726115,schistosomiasis
36726115,aggressive tumor
36725930,metastases and leukaemia
36725930,lung metastases of breast cancer
36725900,benign breast disease
36725810,anaplastic thyroid cancer via machine learning algorithms
36725810,anaplastic thyroid cancer
36725810,malignant cancer
36725727,lymphopenia
36725727,leukopenia
36725727,lung infection
36725727,ventricular tachycardia
36725727,sd
36725670,bone fractures
36725670,cardiovascular symptoms
36725477,skin-flap necrosis
36725367,non-invasive cancer
36724921,organ dysfunction
36724921,liver disease
36724921,cholestasis
36724921,mps
36724921,mpss
36724921,hokuriku branch
36724637,metastasis of liver cancer
36724605,metastases of breast cancer
36724605,head-and-neck cancer
36724586,risks of ovarian cancer
36724402,arkansas cancer
36724251,pruritus
36719848,increase cancer
36719580,numerous breast carcinoma
36719570,ductal cancer
36719570,slnds
36719494,myeloma
36719494,vertebral osteolytic metastases
36719454,breast adenoid cystic carcinoma
36719288,supplemental breast cancer
36719288,incremental cancer
36719288,situ disease
36719264,synovial sarcoma
36719061,multi-cancer
36718985,ewing's sarcomas
36718985,central nervous system tumours
36718971,spinal cord cancers
36718280,acute kidney injury
36718225,type 2 diabetes mellitus
36718018,epithelial ovarian carcinoma
36718018,fallopian tube cancer
36718018,primary peritoneal carcinoma
36717797,palbociclib plus endocrine
36717788,malignant breast cancer
36717689,endothelial dysfunction in breast cancer
36717689,psychosocial stress
36717553,liver and breast cancer
36717520,breast's tumor
36717454,motility of breast cancer
36717320,upper pole lesion
36717320,breast ptosis
36717163,para-aortic lymphadenectomy
36717163,para-aortic lymph
36716530,fertility anxiety
36716529,beck depression
36716418,hurria
36716280,aggressive cancer
36716084,hodgkin disease
36716084,classic hodgkin lymphoma
36716084,nodular sclerosis
36716084,pediatric hodgkin lymphoma
36716084,myeloid leukemias
36716075,iii lung cancer
36715845,invasive ductal cancer
36715835,illness beliefs impact disease
36715835,diabetes illness beliefs
36715835,diabetes beliefs
36715715,osteoporotic
36715715,osteopenic
36715715,f-bmd and l-bmd loss regardless
36715715,femoral bone loss
36715684,pulmonary disorders
36715684,diabetes mellitus
36715684,hematolgic malignancy
36715493,hereditary cancer syndromes
36715483,breast cancer invasiveness
36715182,hepatocellular carcinoma metastasis
36715182,metastasis of hepatocellular carcinoma
36715126,hepatic toxicity
36715126,liver disorders
36714596,euthyroidism
36714582,hepatocellular cancers
36714402,breast fibroadenoma and breast cancer
36714379,mbd
36714356,tn tumors
36714346,contralateral breast cancer
36714346,arthralgia
36714331,cancerous dendritic
36713841,degenerative degeneration of neurons
36713841,neuroinflammation and neuronal death
36713695,skin melanoma
36713573,ewing sarcoma
36713573,aggressive bone
36713573,ewing sarcoma in the absence of infection
36713550,muscle atrophy
36713550,weakness
36713514,atlas breast invasive carcinoma
36713514,tumor immune-inflammation
36713510,vision
36713510,anastomosis of tracheal tumors
36713510,tracheal tumor
36713510,upper trachea
36713510,nerve injury
36713507,atezolizumab plus
36713467,lhhs for haematological toxicities
36713317,rps5-depleted cancer
36713167,klebsiella
36713167,nosocomial infection
36712947,familial hyperkalemic hypertension
36712945,drug toxicities
36712945,hepatorenal toxicity
36712480,diabetes-related cancers
36712480,"endometrial, ovarian, bladder"
36712480,kidney cancers
36712480,breast and endometrial cancers
36712480,hyperglycemia
36712480,hyperinsulinemia
36712364,tumor inhibition
36712364,frank tumor
36712357,cognitive abilities
36712139,ipqtls
36712139,cardiac damage
36712139,heart damage
36711885,beat cancer
36711811,stresses
36711751,endows tumor
36711732,colon and breast cancer
36711732,necrotic tumor
36711554,small cell lung cancer
36711554,glioma growth
36711554,breast cancer brain metastasis growth
36711554,pancreatic and gastrointestinal cancers
36711554,sclc
36711554,sclc brain metastases
36711554,sclc tumors
36711554,lung tumor
36711554,sclc initiation
36711546,insomnia
36711437,papillary thyroid cancer
36711437,ovarian tumor
36711437,ovarian goiter
36710995,smds
36710732,psychosocial symptoms
36710732,insufficient pain
36710655,non-small-cell lung cancer
36710380,"artery atherosclerosis, cardioembolism"
36710380,skin lesion
36710380,calcification
36710380,liver fibrosis
36710380,brain injury
36710380,intracranial hemorrhage
36710380,cranial fracture
36710380,alzheimer's disease
36710380,cognitive disability
36710350,cervical squamous cell carcinoma
36710348,obesity and breast cancer
36710348,ob-at bascs
36710348,low malignant breast cancer
36710348,malignancy of breast cancer
36710237,anxious
36710145,gonadotoxicity
36710119,absence of obesity
36709639,synchronous or metachronous ombc
36709501,cancer metastasis
36709314,hereditary colorectal cancer syndrome
36709314,familial adenomatous polyposis
36709314,neoplasms
36709314,familial colorectal cancer type x (fcctx) syndrome
36709314,familial colorectal aggregation
36709238,deepness
36709125,hand foot syndrome
36709125,abnormal liver function
36709091,breast cancer brain metastases
36709091,neurological symptoms
36709040,hr+her2- tumours
36709040,homologous recombination deficiency
36709040,hr+her2-ebc
36708898,cancer disorders
36708898,high efficiencies
36708898,drug entrapment
36708693,chhip
36708693,prostate tumours
36708582,axillary web syndrome
36708582,numbness
36708582,lymphostasis
36708582,impairments in breast cancer
36708582,lymphedema.pain
36708551,human diseases especially cancers
36701415,ml algorithms
36701152,thoracic cancers
36701152,esophageal cancers
36701152,urologic cancers
36701134,mastitis
36701095,aggressive tumour
36700645,death 1 (pd-1) checkpoint blockade
36700593,salmonella choleraesis
36700469,decreased carcinogenesis
36700469,bc malignancy
36700242,bmd
36700242,vertebral fractures
36700242,fractured
36700242,inertia
36700147,cytotoxicity of psc
36699993,acute pain
36699993,pain unpleasantness
36699789,benign-appearing fibroepithelial lesion
36699789,fibroepithelial lesion
36699456,basal breast cancer
36699456,chemoresponsiveness in breast cancer
36699453,multidimensional cancer
36699449,cell renal cell carcinoma
36699449,ccrcc
36699449,clear cell renal cell carcinoma tumor
36699222,mental illness
36699222,anxiety disorder
36698865,deep learning algorithm
36698767,bayesian variational autoencoder
36698640,dds
36698553,malignant breast disease
36698436,genetic disease
36698422,primary squamous cell carcinoma
36698280,bladder tumors
36698037,invasive breast carcinoma
36698037,pls
36697389,vaginal atrophy
36697389,hypoestrogenism
36697317,pten-loss tumours
36697317,hyperglycaemia
36697317,pten-loss
36697107,metastatic colorectal cancer
36697107,crc liver metastases
36697093,spinal cord metastases
36697070,hypoxic tumor
36697070,hypoxia-resistant breast cancer
36697070,hypoxia-resistant tumors
36697070,hr-positive breast cancer
36697069,fallopian-tube cancer
36697069,myelodysplastic syndrome
36697065,ces
36697057,-breast-tumor
36697057,sexual wellbeing
36696936,valepotriate-type iridoids
36696934,aggressive malignancy
36696853,tisotumab
36696819,vulvar melanoma
36696637,vaginal dryness
36696637,dryness
36696440,neurological disorders
36696357,tle3 sustains luminal breast cancer
36696336,fibrosis in lymphedema
36696336,lymphatic injury
36696309,postoperative lymphedema
36696309,synchronous contralateral breast cancer
36696306,primary breast augmentation
36696306,augmentation-mastopexy
36696303,gigantomastia
36696302,hdhps
36696263,sensations
36696238,esophageal cancer
36696184,thromboembolism
36696184,metastatic disease
36696184,thrombosis
36696184,venous and arterial thromboembolic
36695998,mcf7 breast cancer
36695978,itching
36695975,synchronous versus metachronous metastatic disease
36695975,non-small-cell lung carcinoma
36695902,intraoperative blood loss
36695824,depressive symptoms
36695647,cem scheduling
36695306,noninvasive malignant breast disease
36695128,hepatic steatosis
36695128,thigh myosteatosis
36694990,deprive tumours
36694990,aggressive mcf7 cancer
36694940,human breast cancer
36694918,latina breast cancer
36694918,hereditary breast and ovarian cancer
36694918,hereditary breast and ovarian cancers
36694785,breast diseases
36694772,breast cancer mcf-7
36694726,deadly disease
36694702,"ovarian, osteosarcoma"
36694702,metastasis of prostate cancer
36694670,situ cancer
36694633,tumor diseases
36694535,postoperative seroma
36694511,synchronous primary malignancy
36694511,tumors synchronously
36694497,breast lymphomas
36694497,lymphomas
36694417,fasciitis
36694417,periosteal fasciitis
36694417,chondrosarcoma
36694240,calcification in breast cancer
36694222,non-breast cancer death
36694207,foreign body injury
36694207,mental disorders disease
36694205,skin flap ischemia necrosis
36694205,ischemia necrosis
36694205,ischemia
36694205,blood loss
36694138,breast abscess
36694138,reptiles of pyogranulomatous infections
36694138,painless breast abcess
36694138,hematic telorrhea
36694005,liver homeostasis
36694005,solid cancers remotely disrupt liver homeostasis
36694005,liver zonation
36693714,papillomatous breast lesions
36693714,papillomas
36693714,ccl
36693714,papilloma
36693714,breast neoplasias
36693540,tumorectomy
36693540,left breast invasive ductal carcinoma
36693438,dha
36693175,blood tumor
36693068,lymphovascular niche
36693064,ddp breast cancer
36692882,white breast cancer
36692882,black breast cancer
36692820,cardiotoxicity of anti-cancer
36692820,toxicities of cancer
36692820,cardiotoxicity across multiple disease
36692704,lci
36692641,high tumoral
36692626,smd
36692585,malignant breast cancers
36692349,cystic metastases
36692349,oral lesions
36692298,high breast cancer
36692120,icds
36691884,her2-low disease
36691884,lung disease
36691884,ild
36691829,pancreatic tumor
36691586,rethinking pityriasis rubra
36691586,paraneoplastic syndrome
36691586,pityriasis rubra pilaris
36691410,cardiomyopathy
36691410,hf
36691400,endometrial intraepithelial neoplasia
36691400,endometrial intraepithelial neoplasia and endometrial cancer
36691400,abnormal bleeding
36691400,abnormal uterine bleeding
36691400,endometrial lesions
36691400,cancerous diseases
36691400,precancerous disease
36691113,melanoma stemness
36691113,melanomas
36691057,hiv
36691057,cerebrovascular diseases
36691057,cvd
36691057,asthma/chronic obstructive pulmonary disease
36691057,tuberculosis
36691014,cybersickness symptoms
36690836,liver and lung cancer
36690836,liver and endometrial cancer
36690822,dcis
36690653,mrd
36690530,decreased breast cancer
36690238,mcf-7 breast carcinoma
36690157,kaposi sarcoma
36690079,erbeta-targeted breast cancer
36690054,bone malignancy
36690036,acidity deficiency
36689989,quadriceps muscle thickness
36689699,breast disease
36689646,liver failure
36689250,her2-positive breast cancers
36689250,tumour necrosis
36689066,pericardial metastases
36689059,vulvar carcinoma
36689059,cervical carcinoma
36689059,vulva carcinomas
36689059,malignancies as breast or ovarian cancer
36689059,vulvar carcinoma of the condylomatous
36689059,vulvar carcinomas
36689055,amenorrhea
36689055,ovarian toxicity
36689055,hypophysitis
36689055,ovaries
36689055,"ovarian transposition, ovarian"
36689055,fertility loss
36689007,primary tumour
36689007,luminal tumours
36689007,tnbc tumours
36688919,melanoma and breast cancer
36688860,breast skin necrosis
36688470,altered glucose
36688470,pancreatic (aspc-1) cancer
36688111,"bladder, prostate and ovarian cancer"
36688062,loss of retinoblastoma
36688045,edema
36688016,neurological diseases
36688016,colorectal epithelial disorders
36687259,carcinoma breast revisited-a tertiary cancer
36687259,breast deformity
36687259,postoperative flap complications
36687257,sln metastases
36687257,metastases increases
36687252,carcinoma breast
36687247,hernia
36687247,incisional hernia
36687228,bl tumours
36687223,pancreatic cancers
36687217,breast and ovarian cancers
36686840,breast cancer brain metastasis
36686840,bc brain metastasis
36686840,central nervous system disease
36686832,ii-iii breast cancer
36686831,ihl
36686817,silent gastric cardia adenocarcinoma
36686817,polyuria-polydipsia syndrome
36686817,generalized asthenia
36686817,panhypopituitarism
36686817,bitemporal hemianopsia
36686817,adenocarcinoma of the gastric cardia
36686817,gastric cardia
36686817,pituitary metastases
36686817,gastric cardia adenocarcinoma
36686817,sudden onset of diabetes insipidus
36686817,visual deterioration
36686812,osteoblastic bone
36686775,tumor inflammation
36686769,liver malignancies
36686746,localized breast cancer
36686740,choriocarinomatous features
36686740,choriocarcinoma
36686740,choriocarcinomatous
36686735,genetic anomalies
36686618,sexual behaviors
36686311,carcinoma prostate
36686311,metachronous carcinoma breast
36686303,epstein-barr virus infection
36686303,left breast carcinoma
36686303,schminke type of lymphoepithelial cancer
36686303,lymphoepithelial malignancy
36686300,subcutaneous t-cell lymphoma
36686300,panniculitis
36686300,panniculitis-like t-cell lymphoma
36686300,cutaneous lymphoma
36686300,erythematous
36686300,b t-cell lymphoma
36686300,cutaneous lymphomas
36686245,hyperpyrexia
36686229,viral infection
36686229,melanoma tumors
36686170,asthma
36686129,silent female breast cancer
36686129,silent breast cancer
36686129,silent breast cancers
36686127,gynecomastia
36686127,gynecomastia or breast swelling
36685971,cervical squamous cell carcinoma and endocervical adenocarcinoma
36685963,malignant
36685963,breast abnormalities
36685922,tumors and breast cancer
36685907,chronic obstructive pulmonary disease
36685907,copd
36685904,atlas breast cancer
36685821,basal tumors
36685583,necrosis periphery
36685583,invasive tumor
36685551,appendiceal goblet cell carcinoma
36685551,paraneoplastic neurological syndromes
36685551,appendiceal tumors
36685551,psychiatric symptoms
36685551,hypotension
36685551,paraneoplastic amphiphysin-igg-positive encephalitis
36685551,pnss
36685551,paraneoplastic cerebellar dysfunction
36685506,blood coagulation
36685105,cancer stroma
36685105,aggressiveness of the tumor
36685105,invasive breast carcinomas
36684705,carcinoma of left breast
36684705,ear
36684697,tpss
36684638,mucinous breast cancer
36684416,bd breast cancer
36684405,non-pcr breast cancer
36684404,venous failure
36684401,completely remove t1 breast cancers
36684401,small breast cancer
36684401,small breast cancers
36684376,breast cancer lung metastasis
36684376,bone metastasis
36684345,brachiocephalic vein
36684343,breast seromas
36684253,pulmonary tuberculosis
36684253,malignant pleural effusion
36684253,tuberculous pleural effusion
36684105,"cancer-melanoma, breast cancer"
36683684,coronavirus infections
36683495,thymoma
36683495,hodgkin's lymphoma
36683495,anaplastic thyroid carcinoma
36683495,sarcomatoid urothelial carcinoma
36683495,tumors of haematopoetic
36683495,merkel cell carcinoma
36683495,serous carcinoma of the ovary
36683495,intestinal gastric adenocarcinoma
36683495,liposarcoma
36683493,breast atypical ductal hyperplasia
36683493,ductal hyperplasia
36683273,ao
36683230,advanced breast cancer lung metastasis
36683230,retention of chemotoxic
36683225,parabens strongly impaired tumor
36683225,breast cancer metastasis
36683161,hematotoxicity
36683066,cardiovascular toxicities
36683066,cognitive decline/dementia
36682796,head-and-neck squamous cell carcinoma
36682796,glucose-deficient
36682767,metaplastic breast carcinoma
36682767,myocardial infarction
36682767,obstructive coronary disease
36682767,hyperkalemia
36682767,myocarditis
36682767,pericarditis
36682767,takotsubo and brugada syndrome
36682767,chest pain
36682767,hypotonia
36682767,acute coronary syndrome
36682767,neoplastic cachexia
36681577,skin necrosis
36681070,cancers initiation
36681070,tn breast cancer
36681013,pertuzumab plus trastuzumab
36681013,cardiac death
36681013,cardiac advisory board
36681013,cardiac deaths
36680689,hypertrophy
36680689,impairs liver regeneration
36680689,colorectal liver metastases
36680689,dh
36680689,hyperbilirubinemia
36680689,flr hypertrophy
36680672,falling asleep
36680352,mood symptoms
36680352,hads anxiety
36680276,hspgs
36680276,viral infections
36680276,hepatocellular carcinomas
36680276,sars-cov-2 infections
36680222,hadv-c6
36678870,adverse drug reactions
36678741,tumour accumulation
36678715,dehydration
36678711,breast cancer efficiencies
36678601,hmbc
36678601,embryonic lung
36678593,epithelioid cervix carcinoma (hela) cancer
36678556,gastrointestinal diseases
36678509,tnbc metastasis
36678292,ovarian cancer in the ovarian cancer
36676849,tumour aggressiveness
36676849,protozoan parasites
36676756,sexual symptoms
36676710,mucinous carcinomas
36676710,intraductal carcinoma
36676192,hpv infection
36676192,psp
36676192,breast tumour
36675817,diabetes-associated breast cancer
36675817,lipid metabolism disorders
36675817,metabolic abnormalities
36675704,breast cancer lung metastases
36675536,lung adenocarcinoma a549
36675457,cov-2 infection
36675434,hgwd
36675400,horner's syndrome
36675400,blepharoptosis
36675400,miosis and anhidrosis
36675400,goiter
36675400,cancer-hs
36675400,hypocalcemia
36675400,fistula
36675400,hypertonic glucose
36675400,lymphorrhoea
36675343,mental disorders
36675341,syngeneic breast cancer
36675340,pcp-altered breast cancers
36675239,myelodysplastic syndromes
36675239,adrenocortical carcinoma
36675138,oral squamous cell carcinomas
36675138,oscc tumor
36674955,blbc aggressiveness
36674951,pd-l1-negative tumors
36674951,pd-l1-positive tumors
36674914,"colorectal, endometrial, ovarian"
36674870,brain cancers
36674870,intestinal helminthiasis
36674870,brain cancer
36674836,hh
36674836,medulloblastoma
36674836,pancreatic carcinomas
36674831,apoptosis/pyroptosis in mcf7 breast cancer
36674782,colorectal metastases
36674782,melanoma and colorectal metastases
36674773,lymphovascularinvasion
36674719,osteolysis
36674696,mcss
36674696,hms
36674656,hormone-responsive breast cancer
36674567,stomach cancers
36674567,ddss
36674562,idiopathic granulomatous mastitis
36674562,benign inflammatory breast disease
36674562,lactational mastitis
36674436,non-metastatic breast cancer
36674436,cross-linked n-telopeptide
36674436,bone-loss
36674247,amns
36674237,jordan's cancer
36673757,pa behaviors
36673675,sleep disorders
36673675,ns
36673448,neoplastic tumors
36673037,cervical cancer
36672989,cancerous breast lesions
36672989,cancerous lesions
36672885,high glucose increases
36672885,elevates
36672847,familial breast cancer
36672665,creutzfeldt-jakob disease
36672645,skin squamous cell cancer
36672633,tnbc-tumor
36672633,imt plus ptx decreased hypoxia
36672465,chordoma and eye melanoma
36672465,eye melanoma
36672461,left ventricular function
36672454,mitotic block
36672454,mitotic arrest
36672434,gallbladder cancer
36672434,obesity increases cancer
36672434,obesity-associated cancers
36672419,hm tumors
36672417,cancer disease
36672375,aws
36672368,menarche
36672367,iii colon cancer
36672367,sitc
36672357,british columbia
36672357,nova scotia
36672351,tnbc spheroid
36672349,tnbc tumor growth
36672349,aggressive luminal
36672349,tnbc aggressiveness
36672344,myasthenia gravis
36672332,hbc
36672332,intra-tumoral
36672329,malnutrition
36672329,sarcopenia
36672329,cancer cachexia
36672302,genetic disorder
36672302,hereditary nonpolyposis colon cancer (hnpcc) or lynch syndrome
36672302,sporadic colon carcinomas
36672285,inflammatory breast carcinoma
36671922,machine-learning algorithms
36671896,discrimination of breast cancer
36671744,adult breast cancer
36671659,cancer aggressiveness
36671637,ductal carcinoma in situ and breast cancer
36671532,breast invasive ductal carcinoma
36671421,poisoning
36671322,colon carcinoma
36671322,infected
36671322,ulcers
36671322,skin lesions
36671001,melanoma and ovarian cancer
36670996,tumor-bearing elrich ascites carcinoma
36670996,lymphoma ascites
36670996,tumor weight
36670508,tumour growth
36670280,neuroendocrine neoplasms
36670203,pancreatic ductal adenocarcinomas
36669994,multicentric tumors
36669282,upper extremity unilateral lymphedema
36669282,unilateral lymphedema
36669078,primary cutaneous ewing sarcoma
36669078,cutaneous ewing sarcoma
36669078,blue-cell tumors
36669078,blue cell tumors
36662868,cullin-5 deficiency orchestrates the tumor
36662868,brca1 deficiency to promote tumorignesis
36662868,cullin-5 deficiency
36662868,blocked tumor
36662756,pni deteriorated os
36662485,traumatic stress disorder
36662485,mental health disorders
36661746,breast cancer-a
36661710,cancer tdm
36661703,myosteatosis
36661685,primary bile duct
36661673,hypothalamic-pituitary-adrenal (hpa) axis
36661672,cardiotoxicity of cancer
36661672,cvd deaths
36661654,non-alcoholic fatty liver disease
36661654,fatty liver disease
36661654,hepatic dysfunction
36661652,primary malignancies
36661652,colon-rectal cancer
36661524,apoptosis in breast cancer
36661524,tumor-necrosis
36661524,tumor necrotic
36661506,bt-474 breast cancer
36661506,bone marrow
36661325,genotoxicity of stress
36661285,metastatic disorders
36660883,dysfunction
36660883,lv gls deterioration
36660883,lv dysfunction
36660838,colon and lung cancers
36660717,occult breast cancer
36660685,papillomavirus infection
36660662,ob
36660646,ibc
36660637,neoadjuvant pertuzumab plus trastuzumab
36660626,postoperative breast cancer
36660608,venous congestions
36660608,pulmonary embolism
36660589,breast microtumor
36660589,adipose stroma
36660589,hypertrophic adipose stroma
36660589,obesity-associated breast cancer
36660366,"breast, ovarian, pancreatic or prostate cancers"
36660299,invasive bladder cancer
36660299,lymphovascular invasion
36660211,neutropenia in breast cancer
36660209,loss of tumor
36660209,leukemias and lymphomas
36660090,social dysfunction
36660064,cardiotoxicity in breast cancer
36660064,aic
36660064,ventricular systolic dysfunction
36660064,breast cancer aic
36659929,nephrotoxicity
36659929,tumor ecs
36659929,multi-cancer ec atlas
36659929,non-prostate cancers
36659836,gastric
36659828,carcinoma erysipeloides
36659828,cutaneous metastases of breast cancer
36659828,cutaneous metastatic breast cancer
36658690,dendritic
36658690,allergy
36658674,neuropathic symptoms
36658635,breast (brca) or prostate cancer
36658611,he
36658409,mitosis
36658409,faithful mitosis
36658409,hela cervical cancer
36658409,neurodevelopmental disease-linked mitotic regulators champ1
36658256,primary tumors
36658130,paraptosis in breast cancer
36658130,af
36658130,af plus bz induced paraptosis
36657931,e genotoxicity
36657923,low gastrointestinal chemotoxicity
36657563,tumor invasiveness
36657563,breast cancer cell invasiveness
36657553,ingrt-palm nps
36657483,breast cancer aggressiveness
36657304,her2-breast cancer
36657301,mushrooms blend
36657301,cerebellar metastases
36657260,gliomas
36656750,intracranial malignancy
36656750,luad primary tumor
36656642,skin damage
36656642,dermal necrosis
36656642,degeneration
36656633,openness
36656633,hereditary breast and ovarian cancer (hboc) syndrome
36656510,her2-zero tumors versus her2-low-positive tumors
36656510,her2-zero tumors
36656469,pheochromocytoma and abdominal paraganglioma
36656469,tumors metastasize
36656338,non-metastatic prostate cancer
36656338,ovarian failure
36656238,osteosarcomatous differentiation
36656238,breast neoplasms
36656238,aggression
36656142,tumour metastasis
36655820,psychomotor
36655818,lcd
36655818,middle pnbc block giving rise
36655723,ncl
36655686,scutellaria baicalensis georgi in breast cancer
36655350,fanconi anemia
36655184,primary cutaneous mucinous carcinoma
36655184,malignant skin adnexal tumor
36655184,metastasis of mucinous breast cancer
36655184,metastasized breast cancer
36655089,metabolic disorders
36654912,luminal a breast cancer
36654822,invasiveness
36654721,obstruction
36654721,invasive lobular breast cancer
36654721,right breast lobular carcinoma
36654721,lobular carcinoma of breast metastasising
36654601,high toxicity
36654601,hematological neoplasms
36654601,systolic dysfunction
36654601,atrial flutter
36654601,arrhythmias
36654075,melanoma and colon cancer
36653923,aggressive tumor behavior
36653795,hypervascular lesion
36653795,clear renal cell carcinoma
36653541,inherited disease
36653507,breast cancer pd-l1
36653080,immunosuppressive tumor
36653041,breast burkitt's lymphoma
36653041,unilateral disease
36653041,primary breast burkitt's lymphoma
36652988,fibrous dysplasia/mccune-albright syndrome
36652988,fd
36652988,abnormal bone turnover
36652909,breast primary cancers
36652804,hardness-eta
36652804,atoms c5
36652734,metastasis of tumors
36652667,er-positive breast cancer
36652665,high hrd
36652140,analgesia
36652140,postoperative impaired sleep
36652140,stellate ganglion block
36652115,epithelial malignant tumor
36651629,situ breast carcinoma
36651218,colorectal and gastric cancers
36650998,n atoms
36650834,pulmonary metastasis
36650758,myeloid dendritic infiltration in breast cancer
36650679,smoke and disease
36650679,respiratory system diseases
36650408,tumor stroma
36650292,glioma tumors
36650292,axl-h tumor
36649695,breast and urothelial cancer
36649695,papillary urothelial carcinoma
36649695,carcinoma of the skin
36649695,invasive urothelial carcinoma
36649695,t-cell lymphoma
36649695,squamous cell carcinoma of the skin
36649695,colorectal neuroendocrine carcinoma
36649303,blood malignancies
36649274,longitudinal multiparametric mri
36649030,glioma and glioblastoma
36648988,ductal carcinoma in situ using deep learning algorithms
36648694,metachronous metastatic disease
36648694,bone only disease
36648694,tumours and liver or brain metastases
36648694,metachronous metastases
36648693,arthritis
36648693,autoimmune diseases
36648693,torsion
36648270,cutaneous melanoma wide
36648270,cutaneous melanoma lesions
36647951,central nervous system diseases
36647951,prostate diseases
36647948,acute radiation dermatitis
36647948,ard
36647948,tender erythema
36647940,microbial invasive infection
36647940,novel coronavirus disease
36647940,novel tumor
36647940,hematologic tumors
36647940,anorexia
36647940,intestinal mucositis
36647940,bone marrow suppression
36647342,black breast and ovarian cancer
36647026,hereditary tumor syndrome
36646788,liver tumour
36646707,niche stiffness sustains cancer stemness via taz
36646538,slnd
36646538,tads
36646538,alnds
36646376,cardiovascular illnesses
36646376,gastroesophageal reflux disease
36646376,bacterial infections
36646376,gastritis
36646350,aids-related kaposi sarcoma
36646229,hbv-infected
36646021,deep learning algorithms
36645966,chronic illness
36645554,aggressive behaviors of tumor
36645554,tn
36645462,papillary carcinoma of the breast
36645346,breast lymphedema
36645346,gastroepiploic vessels
36645194,sporadic ovarian cancers
36645194,trachea
36645194,fallopian tubes
36645168,visual working memory
36645168,stage i disease
36645168,cognitive loss
36645113,intrahepatic cholangiocarcinoma
36644870,numerous tumor
36644870,neuroblastoma
36644690,metabolic disease
36644191,breast mcas
36643360,postoperative infection
36643360,remote infection
36642942,esophageal-gastrointestinal cancers
36642837,breast cancer cancer
36642742,her2-positive breast cancer brain metastases
36642125,invasive or ductal carcinoma
36642066,breast or ovarian cancer
36642066,quasi-binomial
36641927,alpelisib in cancers
36641927,alpelisib in breast cancer
36641897,multidisciplinary tumour board
36641706,ovaria cancer
36641658,thrombocytosis
36641658,preoperative thrombocytosis
36641657,tumor lesions
36641653,situ breast cancer
36641652,tuberculous adenitis
36641652,breast lymphadenopathy
36641652,tubercular lymphadenopathy
36641652,tuberculous lymphadenitis
36641652,lymphadenitis
36641652,axillary tuberculous lymphadenitis
36641651,non-cancerous
36641650,deficiency or insufficiency
36641323,mastalgia
36641323,breast pain
36641323,mastalagia
36641322,ehrlich ascites carcinoma
36641322,cytotoxic t
36640423,n-cqds
36640372,pancreatic neuroendocrine tumor
36639918,pressure-pain
36639824,cafs
36639824,melanoma malignancy
36639824,cm
36639824,mir-214-rich evs of stroma
36639771,ovarian and hepatocellular cancers
36639610,cognitive problems
36639178,hyperparathyroidism
36638937,negative breast cancer
36638314,microinvasive carcinoma
36638256,ncp
36638208,lmd
36638194,igm
36638194,mastitis and breast cancer
36637961,rectal carcinoma
36637961,splenic malignancies
36637961,lymphocytic tumors
36637775,loss of ovarian hormone
36637704,rare disease while prostate cancer
36637704,breast/prostate cancers
36637642,primary tumor
36637642,ea-ftc
36637642,mi-ftc
36637391,cephalaria
36637236,colorectal and breast cancer
36637236,hand-foot syndrome
36637138,pain neuroscience
36637138,pain neuroscience education
36636578,embryonic kidney
36636094,desmoplastic stromal reaction
36636094,tumor-stroma
36636094,stage ii colorectal cancer
36636090,hepatic dominant solid tumors
36636090,liver dominant diseases of solid tumors
36636090,pancreatic neuroendocrine tumors
36635954,breast ductal carcinoma
36635954,tlss
36635954,tlsshigh
36635367,neoplastic disease
36635367,breast neoplasia
36635367,pten tumor
36635337,immunologic memory upon tumor
36635273,cafs (icafs) and myofibroblastic cafs
36635249,hads-t
36634956,hypertrophic
36634822,cardiovascular adverse
36634822,cardiovascular toxicity
36634708,fibrosarcoma
36634708,liver dysfunction
36634640,peritoneal effusion
36634607,ovarian function
36634566,qtls
36634378,drug resistant breast cancer
36634299,cowden syndrome
36634299,colon polyposis
36633855,hypoparathyroidism
36633813,intra-tumoral akt
36633813,biliary excretion
36633813,renal impaired
36633813,hepatic impaired
36633714,tumor malignancy
36633714,tumor malignance
36633525,corpus cancers
36633525,papillomavirus-associated cancers
36633402,enabling disease
36633334,attenuated breast cancer
36633307,breast and lymphohematopoietic cancers
36633148,biliary tract cancer
36633143,bronchitis
36633143,saha
36633115,postoperative analgesia in breast cancer
36633028,multinodular skin lesion
36632974,india's cancer
36632594,thyroid benign tumors
36632594,parathyroid benign tumors
36632594,benign neck tumor
36632594,blood s-fn-positive thyroid cancer
36632589,i-iii colorectal cancer
36632557,upper limb muscle metastasis
36632557,melanoma metastases
36632451,invasiveness of breast cancer
36632451,metastasis of the disease
36632303,skin toxicities
36632303,pneumonitis
36632291,esophagitis
36632235,mitochondrial damage and dysfunction
36632235,cancerogenesis and heart disease
36632235,mitochondrial damage
36632235,mitochondrial injury
36632235,cardiac fibrosis
36632235,myocardial oxidative stress
36632235,mitochondrial abnormalities
36632235,mitochondrial damage and cardiomyopathy
36632055,radiation skin reaction
36632055,tenderness and swelling
36631781,benign breast tumor
36631781,malignant breast tumor
36631781,breast malignant lesion
36631777,block versus paravertebral block
36631631,migraine
36631631,migraine headaches
36631631,migraine headache
36631631,menarche separately
36631631,behavioral symptoms
36631561,stress reduction
36631533,bacterial dysbiosis in breast cancer
36631481,retarding breast tumor
36631481,abnormal tumor
36631481,retard tumor
36631400,tubular carcinomas
36631282,glycoside condensation reaction
36631282,lps
36631217,endocrine-dependent tumors
36631217,endocrine-dependent cancers
36631161,a breast cancer
36631161,immunogenic tumor cell death
36631161,tumor lesion
36631161,contralateral tumor
36631161,cytotoxic tumor
36631151,sarcoma of the breast
36631151,smooth muscle tumors
36631151,endometrial stroma sarcomas
36630916,memory t
36630913,lung tumors
36630755,metastatic bone disease
36630755,osteolytic bone loss
36630669,photonic hyperthermia
36630665,ncd
36630665,ncds
36630514,tumor toxicity
36630483,pancreatic and lung cancers
36630483,chemoresistant pancreatic
36630266,dic
36630025,tumor death
36630025,non-tumor
36629620,breast and cervical cancer
36629320,glioma and melanoma
36629192,fgds
36629093,bilateral tumors
36628983,mood disturbance
36628681,chronic dyspnea
36628681,dyspneic
36628681,heart palpitations
36628617,metabolic dysfunction
36628282,ips
36628280,hfrs
36628280,non-metastatic disease
36628238,malignant adenomyoepithelioma
36628238,myoepithelial components
36628238,cystic cancer
36628238,malignant leafy tumor
36628082,resistant radiation retinopathy
36628082,decreased vision
36628082,cystoid macular edema
36628082,microaneurysms
36628082,multiple microaneurysms
36628082,radiation maculopathy
36628082,radiation retinopathy
36628036,hfds
36628009,pleural metastasis
36628009,pleural metastasis of breast carcinoma
36627781,"nsclc, ovarian cancer"
36627781,drug toxicity
36627665,right upper lung cancer
36627665,upper lobe lung cancer
36627665,postoperative complications
36627610,endocrine disorders
36627610,respiratory diseases
36627367,non-invasive breast cancer
36627285,responsive disease
36627281,ea tnbc
36627281,ea tnbc tumors
36627143,tumors of breast cancer
36627096,a cancers
36627051,breast and stomach cancers
36626703,benefits of ovarian and endometrial cancer
36626570,palmoplantar keratoderma
36626570,hyperkeratosis
36626570,orthokeratosis and parakeratosis
36626455,loss of skeletal muscle mass
36626455,sarcopenic and nonsarcopenic
36626437,colorectal and prostate cancer
36626432,squamous cell lung cancer
36626432,colorectal malignancies
36626428,upper extremity edema
36626076,coronavirus disease
36626076,latissimus dorsi
36626076,dorsal lymphadenopathy
36625985,lung carcinoma cancer
36625746,ipsilateral invasive breast cancer
36625713,ellipsoid tumors
36625629,address tumor
36625545,dolomiaea costus
36625545,ulcerative colitis
36625545,stomach cancer
36625545,pulmonary fibrosis
36625501,cognitive impairment in breast cancer
36625501,reduced emotional distress
36625501,emotional distress
36625001,phototoxicity
36624500,atherosclerosis
36624452,parental tumors
36624318,osteoporotic cancer
36624318,fn bmd
36624318,vertebral fracture
36624014,migraine and breast cancer
36623765,nic cytotoxicity
36623765,ascites tumor
36623716,hcc tumors
36623716,hcc tumor
36623698,colorectal or gastric cancer
36623698,colorectal or breast cancer
36623589,"glioma, and ovarian cancer"
36623589,tumour vasculature
36623515,anaemia
36623515,sepsis
36623246,low-risk invasive carcinoma
36623246,i-iia breast cancer
36623246,late bone toxicity
36623246,lung toxicities
36623246,bone toxicities
36623176,lupus mastitis
36623176,discoid lupus erythematosus
36623176,cutaneous lupus erythematosus
36623176,lupus
36623176,unilateral lupus mastitis
36622852,candidiasis
36622852,candida infections
36622852,resistant candida albicans infections
36622852,mda-mb-231 breast cancer
36622663,endocrine-resistant breast cancer
36622663,drug-resistant disease
36622663,primary breast tumours
36622544,luminal-b tumours
36622544,luminal-b breast cancer
36622366,neoplastic malignancies
36622109,oestrogen deficiency
36622109,epiphyseal joints
36622109,aromatase deficiency
36622036,2015-2019 california cancer
36622036,skin (melanoma) cancers
36622036,rural disparities jointly
36621857,hematomas
36621620,hbl
36621430,hr- disease
36621430,low vaf
36620882,digital papillary adenocarcinoma
36620882,papillary adenocarcinoma
36620844,breast cancer-related
36620820,vein stenosis imitating inflammatory breast cancer
36620820,breast erythema
36620820,upper extremity deep venous thrombosis
36620820,dvt
36620820,erythema
36620609,her2-negative tumors
36620609,decreased disease-free
36620595,pleural lesions
36620595,pulmonary nodules
36620566,mucinous ovarian carcinoma
36620566,mucinous carcinoma of the ovary
36620168,cell carcinoma
36620168,oval cysts
36620168,epithelial ovarian tumor
36620168,signet-ring cell carcinoma
36620168,primary invasive ovarian tumors
36620166,sln longitudinal
36620166,sln metastasis
36620040,microbe-disease
36619589,bipolar
36619589,migraines
36619482,metastases of adenocarcinoma
36619482,malignant parotid tumor
36618941,"breast, ovarian and cervical cancer"
36618941,ovarian and cervical cancer
36618838,"endometrial, ovarian"
36618838,endometrial and ovarian cancers
36618799,xanthogranulomatous mastitis
36618799,inflammatory mastitis
36618799,cystic neutrophilic granulomatous mastitis
36618799,rosai-dorfman disease
36618799,erdheim-chester disease
36618780,brca
36618780,alabama
36618497,primary breast leiomyosarcoma
36618497,leiomyosarcomas
36618497,breast sarcomas
36618497,breast leiomyosarcoma
36618302,suppression
36617999,cationic amphiphilic chemodrug
36617999,drug-resistant breast tumor
36617953,msigdb
36617941,hrms
36617773,late-stage breast cancer
36617595,critically
36617420,cancerous lung
36617420,small cell carcinoma
36617420,small cell lung carcinoma
36617361,suppression of rb hyperphosphorylation
36617357,multifocal tumors
36617357,aggressive disease
36616659,aggressive type of breast cancer
36616659,granulomatous mastitis
36616371,low-toxicity
36616371,toxicity of sf-agn
36615883,dysgeusia
36615868,habits in breast cancer
36615868,f-fluorodeoxyglucose
36615632,embryonic cardiomyocyte
36615627,overdosage
36615537,chronic disorders
36615474,labelling mcf-7 breast cancer
36615474,mcf-7 cancer cell labelling
36615273,colorectal and anti-breast cancer
36615273,chronic myeloid leukemia
36615273,cml
36615173,tnbcs
36615173,invasive carcinomas
36615173,illumina hiseq
36615096,hysterectomy for benign disease
36615096,high-grade serous ovarian carcinoma
36615096,serous ovarian cancer
36615096,myomas
36615096,adenomyosis
36615096,adenomyomatosis
36615096,right fallopian tubes
36614866,fitness in breast cancer
36614279,lip
36614269,tumoral dermal
36614261,male breast carcinoma
36614209,breast cancer carcinogenesis
36614207,premature ovarian failure
36614207,cognitive and urogenital deficiency
36614200,hormone-sensitive breast cancer
36614200,hdacis
36614168,cytotoxicity in both hepatocellular carcinoma
36614128,liver toxicity
36613820,"colorectal, ovarian"
36613691,breast cancer growth
36613648,hereditary breast cancer
36613648,brca-like tumors
36613590,vaf
36613528,malignancy tumors
36612894,qol breast cancer
36612831,iv breast cancer
36612726,cvd death
36612726,late cardiotoxicity
36612320,hallmarks of breast cancer
36612312,palbociclib pk
36612307,myocardial systolic dysfunction
36612307,mitochondrial damage and endothelial dysfunction
36612241,dysphoria
36612229,enriching cancer
36612229,colon tumour spheroid
36612219,cancer-related fatigue
36612219,cancer-related fatigue in breast cancer
36612219,at
36612209,aggressive triple-negative breast cancer
36612209,aggressive tnbc
36612202,cardiac impairment in breast cancer
36612199,abnormal soce
36612199,cancer invasiveness
36612199,tumoral breast epithelial
36612199,non-tumoral cells impairment of stim1 n-linked glycosylation attenuated
36612199,tumoral breast
36612175,impaired ec tight junction
36612148,human prostate carcinoma
36612065,colon and gastric cancer
36611970,radiosensitivity of hypoxic breast cancer
36611803,hptpeta
36611803,pancreas
36611600,traumatic perception
36611460,low breast tumors
36611457,renal cancers
36611456,lv impairment
36611456,insufficiently
36611456,valve degeneration and heart failure
36611456,thymomas
36611456,rv injuries
36611419,os reduction
36611382,breast cancer malignancies
36611358,deep learning classification of breast cancer
36611165,deficient breast cancer
36611165,deficient (hrd) breast cancer
36611165,hrd breast cancer
36611131,leucopenia
36611099,synchronous ipsilateral supraclavicular lymph
36611099,ipsilateral supraclavicular lymph node metastases
36611099,islm breast cancer
36611079,tumor-only solid tumor
36611070,papillary mucinous neoplasm
36611070,dysplasia
36610826,ischemic complications
36610826,flap necrosis
36610717,mcf-7l breast cancer
36610717,endocrine responsive breast cancer
36610572,low tumor
36610231,carcinoma of the salivary
36610131,ea in breast cancer
36610131,ea on breast cancer
36609913,immunocompetent tnbc breast tumor
36609911,nab-ptx plus t-mab
36609711,breast tumor metastasis
36609627,hepatocarcinogenesis
36609573,male lung cancer
36609573,urinary cancer
36609573,metachronous primary breast cancer
36609573,male lung adenocarcinoma
36609573,bladder papillary transitional cell carcinoma
36609573,prior bladder papillary transitional cell carcinoma
36609573,prior prostate adenocarcinoma
36609573,lung malignancy
36609573,prior prostate cancer
36609389,palbociclib plus letrozole plus trastuzumab
36609236,cystic breast lesions
36609236,cystic lesions
36609033,normoxia or hypoxia
36608634,breast edema
36608382,ii-iv ovarian cancer
36608371,breast metastatic adenocarcinoma
36608325,single breast cancer
36608325,pleural effusions
36608303,pd-1
36607858,autosomal dominant disease
36607858,hamartomas
36607858,macrocephaly
36607858,cerebellar tumors
36607858,hydrocephalus
36607858,lhermitte-duclos disease
36607858,dural arteriovenous fistula
36607858,adenomatous goiter
36607858,multifocal oral mucosal papillomatosis
36607731,angiomyxoma
36607731,benign mesenchymal neoplasm
36607731,angiomyxomas
36607731,myxoid neoplasms
36607731,parenchymal tumors
36607731,myxoid fibroadenoma
36607731,angiomyxoma of breast
36607729,respiratory disease
36607486,california
36607390,colorectal and h&n cancers
36607384,lhermitte-duclos disease related with cowden syndrome
36607384,metastatic lung cancer
36607384,hamartomatous
36607384,hypermetabolic multinodular thyroid goiter
36607384,hamartomatous pulmonary
36607384,hypermetabolism
36607384,cerebellar tumor lesion
36607384,hamartomatous tumors
36607381,malignant axillary lymphadenopathy
36607381,malignant lymphadenopathy
36607099,optic breast cancer
36606484,psed
36606458,carcinoembryonic
36606354,aggressive eccrine tumour
36606302,classification of disease
36606299,hyport
36606299,hyport in breast cancer
36605832,paraneoplastic cerebellar degeneration
36605832,pcd
36605832,aphasia and dyssynergia
36605795,psds
36605795,ultra-small psds
36605795,hydrophilic psds
36605580,lipid nanoemulsions
36605580,hypersensitivity reaction
36605580,hypersensitivity reactions
36605524,ptd
36605467,stage ii breast cancer-related lymphedema
36605467,mld
36605467,stage ii lymphedema
36605467,upper extremity disability
36605467,ii breast cancer-related lymphedema
36605448,intracranial tumors
36605448,squamous cell cancer
36605442,anemic
36605432,bone marrow metastases in breast cancer
36605432,bone marrow metastasis
36605432,metastasis breast cancer
36605428,her2-negative breast cancer
36605227,easy-bleeding
36605227,ulcerated breast tumor
36605227,dorsi flap
36605217,obvious tumor
36605217,abscopal tumor reduction
36605217,abscopal tumors
36605067,metastatic lung adenocarcinoma
36605067,ivb lung adenocarcinoma
36605067,oral dysesthesia
36605067,extremity edema
36605067,respiratory failure
36605067,ischemic heart disease
36605067,viral myocarditis
36605044,epitheliopathy
36604691,snuh first cancer
36604691,sporadic breast cancers
36604679,aln-positive breast cancer
36604648,calcification lesion
36604629,khomas
36604587,invasive ductal lobular carcinoma
36604587,invasive ductal carcinoma (idc) or invasive lobular carcinoma
36604412,hematologic malignancies
36604379,chmp
36604141,stemness of cancer
36604141,cav-1 deficiency in the tumor stroma
36604141,cav-1-deficient
36604141,cav-1 deficiency
36604098,"sarcoma lung metastases, merkel cell carcinoma abscopal"
36603919,hdi
36603850,ovarian serous carcinoma
36603850,brca1-associated ovarian cancer
36603850,benefits tumors
36603784,rheumatoid arthritis
36603784,traumatic injuries
36603770,attenuated tumor
36603672,tumours of m-wnt-tumour
36603414,acute skin toxicity
36603414,covid19
36603414,breast swelling
36603407,cancer-testis
36603139,postoperative nausea and vomiting
36602747,y2(ha)6(h2o)4
36602292,breast and brain tumors
36602287,iii tumors
36602226,her2+hr+ breast cancer
36601799,invasive fungal infections
36601512,colon and brain cancer
36601474,neck cancers
36601474,tam cytotoxicity
36601407,coronavirus pneumonia
36601407,virus infection
36601341,low disease
36601341,her2-negative disease
36601340,breast-to-ovarian cancer
36601278,left breast cancers
36601278,deep-inspiration breath hold
36601161,gastric schwannoma
36601161,gastric mesenchymal tumours
36601161,gastrointestinal tract mesenchymal tumours
36601161,leiomyomas
36601161,gastrointestinal stromal tumours
36601161,schwannomas
36601161,neuroma
36601161,neurilemmomas
36601161,neurinomas
36601161,benign neoplasms
36601161,schwannomatosis
36601161,neurofibromatosis
36601161,neurofibromatosis 2 tumour
36601161,gastric schwannomas
36601022,-positive breast cancer
36600941,osteoarthritis
36600941,joint disease
36600794,primary gastric carcinoma
36600794,gastric metastasis of breast cancer
36600794,gastric outlet obstruction
36600790,breast cancer metastasizing
36600790,invasive lobular cell carcinoma
36600747,ovid
36600747,oncological spine disease
36600747,deep venous thrombosis
36600678,urothelial cancer
36600573,pancreatic and ovarian cancers
36600573,fanconi anaaemia
36600565,tumour-stroma
36600535,von frey perception
36600535,foot numbness/tingling
36600535,fact-tax neuropathy
36600532,para-aortic retroperitoneal lymph
36600517,neoplastic diseases
36600517,deadly cancers
36600447,oncologic disease
36600314,metabolic tumor
36600314,iia
36600313,malignant tumour
36600299,retard breast tumor
36600299,obvious hepatorenal toxicity
36600271,gastrointestinal disorders
36600271,cardiac disorders
36600271,type of disorder
36600271,toxicities of icis
36600271,ici toxicity
36600173,mbf
36600173,neuroendocrine tumour
36600173,lung cancer plus metastases
36600173,colonic and renal cell carcinomas
36600173,"sarcoidosis, pneumonia"
36600173,lung inflammation
36600173,pleural plaques
36599922,metastasis of breast tumors
25905330,common disorder
36599470,glioblastomas
36599395,multidrug-resistant tumors
36599350,icis
36599263,"hela-mdr, ovarian cancer"
36599202,psychological disorder
36599202,depression-like behaviors
36599050,learning impairment
36599048,epilepsy
36599048,painful juvenile fibroadenomatosis
36598637,breast cancer single-cell
36598627,paget disease
36598514,rb-deficient tumors
36598514,rb-deficient tnbc
36598514,rb deficient tnbc
36598179,breast cancer lesions
36598179,malignant lesion
36598163,benign diseases
36598153,norwegian breast cancer
36597635,radiation refractory disease
36597635,thyroid cancers
36597635,spinal metastatic disease
36597590,bacterial infection
36597579,california cancer
36597286,primary epithelioid sarcoma of the pleura
36597286,pleural neoplasm
36597286,malignant pleural mesothelioma
36597286,empyema
36597286,tumorous lesion
36597286,pleural epithelioid sarcoma
36597286,pleural tumor
36597146,tumors in breast cancer
36597014,iii tumours
36596730,non-breast primary cancers
36596730,breast primary cancer
36596380,txr melanoma
36596344,microsatellite instability
36596344,deficiency of mismatch
36596344,pancreatic or endometrial cancer
36596344,biliary cancer
36596330,cancerous tumors
36595835,peripheral neurotoxicity
36595835,neurotoxic symptoms
36595835,tumor drug peripheral neurotoxicity
36595516,malignant lymphoma
36595297,carcinoma in situ or breast cancer
36595297,carcinoma in situ
36594840,classification of breast cancer
36594836,luminal b tumors
36594836,luminal b tumor
36594615,migration arrest
36594564,oesophageal carcinoma
36594564,lvi
36594158,uhd
36594086,impaired cscs
36593822,hypothalamus
36593486,her2-enriched breast cancer
36593480,stage iii colon cancer
36593475,obesity-related cancer
36593166,colon or prostate
36593075,xanthogranulomatous inflammation
36593075,small bowel langerhans cell sarcoma metastases
36593004,situ carcinoma to invasive carcinoma
36592995,cognitive changes
36592995,memory and episodic memory
36592859,dichroism (ecd) calculations
36592859,"hepatoma smmc-7721, human breast cancer mcf-7"
36592859,pheochromocytoma
36592608,uci heart disease
36592580,learning for breast cancer
36592536,deformity
36592506,thymic epithelial tumours
36592506,thymic carcinoma
36586064,slnb
36586037,arrhythmia
36585863,breast metastatic spine cancer
36585863,breast spinal metastatic tumors
36585853,deep inspiration breath
36585729,malignant breast neoplasm
36585623,drfs of breast cancer
36585562,coronary disease
36585562,valvular disease
36585562,cardiac diseases
36585562,mediastinal lymphoma excess
36585450,basal metastases
36585404,atezolizumab increase pcr
36585358,cancer metastasis suppression
36585358,colonized tumors
36585211,liver tumor
36585206,febrile neutropenia in breast cancer
36585206,low wbc
36585196,metastasis in prostate cancer
36585196,hypercalcemia
36585196,bone pain
36585194,blood t
36585170,annual prostate and breast cancer
36585130,non-hodgkin's lymphoma
36585130,nhl
36584854,lung carcinogenesis
36584854,xenograft tumor
36584723,hyperplasia and tumors
36584723,block tumor
36584607,liver metastasis of breast cancer
36584453,oesophageal squamous cell carcinoma
36584453,acidic tumour
36584207,kd
36584059,suspicious breast lesions
36584053,block versus thoracic paravertebral block
36583862,tnbc cancer
36583691,ellipsoidal tumors
36583628,lesion adcs
36583524,radiation-induced acute breast toxicity
36583524,breast toxicity
36583524,acute toxicity
36583306,modelling acute postoperative pain
36582974,thymoma frequently
36582974,left costophrenic recess
36582974,mediastinal disease
36582974,pleural deposits
36582800,human disorders
36582800,osteosarcoma and papillary thyroid cancer
36582800,t cell leukemia
36582800,myocardial ischemia/infarction
36582800,hepatitis b
36582800,multiple sclerosis
36582786,malignant focal breast lesions
36582786,malignant small breast lesions
36582596,diastolic heart failure
36582596,isolated diastolic dysfunction
36582596,leg oedema
36582596,ventricular diastolic dysfunction
36582596,diastolic dysfunction
36582446,decreased weight gain
36582422,hypothyroidism
36582422,ht
36582280,metrorrhagia
36582280,ovarian cyst
36582145,breast and hepatic cancer
36582086,radiation dependence of chronic lymphoid leukaemia
36582086,malignant neoplasms decreases
36582081,heart damage increases
36582081,heart diseases
36582060,gi cancers
36581985,malignant haematological disease
36581948,ighd
36581929,"columnar cell lesions(ccl), lobular carcinoma in-situ(lcis) and atypical ductal hyperplasia"
36581929,tumour-host
36581929,low ng tumours
36581929,high ng tumours
36581893,obese breast cancer
36581893,overweight breast cancer
36581888,retards breast cancer bone metastasis
36581888,bone metastases of breast cancer
36581888,breast cancer bone metastases
36581817,metabolic abnormalities on breast cancer
36581817,2019 or death
36581817,dyslipidemia
36581817,hypertensive
36581696,ovahrdscar
36581696,tnbchrdscar
36581580,phd
36581401,melanoma and lymphoma
36581401,primary tumors metastasizing
36581401,lung neoplasm
36581374,tumors of the brain
36581374,lesions of pancreatic cancers
36581374,prominently pancreatic cancers
36581346,apoptosis of breast cancer
36581345,classification of brain metastases
36581345,colorectal carcinomas
36580998,dermato-adiposal lymphatic flap venous
36580998,upper extremity lymphedema
36580998,lymphosclerosis
36580998,lymphedema qol
36580998,cellulitis
36580827,cutaneous melanoma
36580716,tumor hyperthermia
36580704,breast augmentation in non-cancer
36580423,advanced prostate cancer
36580360,ii unilateral breast cancer
36580006,synchronous bilateral breast cancer
36579996,isolated cancer
36579996,m arrest
36579891,invasiveness in breast cancer
36579812,neutropenic complications
36579754,amphiphilic block
36579726,obesity and sarcopenic obesity
36579554,subacromial pain syndrome
36579554,tendon lesions
36579386,cardiovascular complications
36579386,vascular dysfunction
36579386,vascular toxicity
36579383,breast phyllodes tumours
36579383,fibroepithelial neoplasms
36579383,classification of tumours
36579098,malignant fibrous histiocytoma of the axilla
36579098,synchronous
36579098,left axillary sarcoma
36578949,primary neuroendocrine neoplasm
36578949,breast neuroendocrine neoplasm
36578949,primary hepatic signet ring cell neuroendocrine tumor
36578947,gastric carcinomas
36578947,adenocarcinoma of the stomach
36578933,dilated peritumoral tumor
36578933,dm plus dbt
36578374,ibr-failure
36578092,breast primary tumors
36578038,pancreatic and thyroid cancer
36577676,homeopathy
36577560,invasive apocrine breast cancers
36577555,malignant neoplasm of breast
36577555,deaths by breast cancer
36577370,responsive tumors
36577184,calculus
36577093,mucinous micropapillary carcinoma
36577093,mucoepidermoid carcinoma
36577093,mucinous ductal carcinoma
36576830,secondary lymphedema
36576797,distal sensory polyneuropathy
36576797,thyroid disease
36576677,obesity in breast cancer
36576677,bilateral breast cancer
36576239,ald
36576071,lung invasive micropapillary carcinomas
36576071,invasive micropapillary carcinomas
36575782,gastrointestinal toxicities
36575780,deaths of breast cancer
36575538,sid
36575447,snps
36575361,luminal-like disease
36575224,mds
36575224,skin sensitization
36575195,hypertriglyceridemia
36575195,rash/pruritus
36575102,primary and secondary breast angiosarcoma
36575102,breast angiosarcoma
36575102,primary breast angiosarcoma
36575102,secondary breast angiosarcoma
36574282,hereditary gastric and breast cancer syndrome
36574282,hereditary gastric and breast cancer syndromes
36574187,hepatic metastasized pancreatic ductal adenocarcinoma
36574187,back pain
36574187,hepatic metastases
36574187,increased neuropathy
36574074,sexual schemas
36574048,distress
36573958,duke cancer
36573823,siad
36573531,colorectal neoplasms
36573531,dementia and chronic kidney disease
36573403,tnbc cscs
36573375,cuch-ncs
36573309,msi-high tumors
36573309,hereditary tumors
36573167,nerve palsy
36573035,"gynecomastia, cushing syndrome"
36573035,multiple neoplasia syndrome
36573035,cushing syndrome
36572997,hands deformities
36572997,hand deformities
36572997,deformities
36572997,inflammatory osteoarthritis
36572991,tubo-ovarian high-grade serous carcinoma
36572609,seroma and haematoma
36572609,haematoma and seroma
36572609,haematoma rates
36572609,haematoma
36572609,haematoma rates reduced
36572578,"hyperlipidaemia, atherosclerotic cardiovascular disease"
36572578,osteoporosis and breast cancer
36572422,invasive micropapillary
36572422,neuroendocrine
36572422,hemorrhage
36572324,androgens
36572281,muscle stiffness
36572093,virus-tumour
36572093,small tumours
36571962,abdominal diastasis
36571707,breast-cancer-related lymphedema
36571503,cognitive change in breast cancer
36571503,cognitive functioning change
36571503,cognitive difficulties
36571503,srcd
36571455,survival trends in solid cancers in the nordic
36571455,"melanoma and breast, endometrial and thyroid cancers"
36571455,vulvar cancers
36571455,prostate
36571260,chronic disease
36571260,pwcd
36571260,chronic hepatitis b
36571260,autoimmune disease
36571232,cytotoxicity in colon cancer
36570854,emotional disorders
36570854,psychiatric disorders
36570766,ewing's sarcoma
36570451,chronic neuropathic pain
36570451,depression scale-depression
36570430,skin cancers
36570288,tremendous attention
36570288,afm
36570288,tumor suppression
36570178,cancer cell cytotoxicity
36568373,pan-cancer
36568362,mortalities
36568301,colorectal adenocarcinoma
36568259,endocrine cancer
36568259,thyroid and breast cancer
36568221,end-stage renal disease
36568221,esrd
36568221,ii hand foot syndrome
36568219,oral mucositis
36568176,cancers of prostate
36568144,impacts tumor
36568144,metastasis suppressive tumor
36568060,disability
36568052,hr-tof-ms
36567618,vaginal bleeding
36567618,endometrial thickness
36567618,ovarian cysts
36567450,adenosquamous carcinoma
36567450,high mitosis
36567450,desmoplastic stroma
36567113,stillbirth
36567059,nci-designated cancer
36567059,tumor cancers
36567009,lncap human prostate cancer
36567009,in carcinogenesis
36566714,drug-resistant breast cancer
36566691,acute skin radiation toxicity
36566690,tad
36566517,neurodegenerative disease
36566517,severe deficiency
36566517,concerning cardiovascular disease
36566517,coronary heart disease
36566517,glucose homeostasis
36566517,concerning infections
36566517,respiratory tract infections
36566517,sleep disturbances
36566517,joint pains
36566517,vulvovaginal atrophy
36566113,fatigue reduction
36566113,reduction of fatigue
36566002,delays tumor
36565967,oligorhamnogalacturonans
36565967,ehrlich tumor
36565967,ehrlich tumors
36565918,decreases breast cancer aggressiveness
36565718,non-cancer diseases
36565382,skin and breast cancers
36564922,component of breast cancer
36564279,axillary lymph node metastasis
36564171,"hereditary breast, ovarian and colorectal cancer syndromes"
36563885,myocardial injury
36563298,ovarian metastasis
36563298,endometrial metastasis
36563141,cardiac toxicity
36562927,impairing tumor
36562609,neck squamous cell cancer
36562524,gastric adenocarcinoma
36562524,hereditary diffuse gastric carcinoma syndrome
36562524,hereditary diffuse gastric cancer syndrome
36562476,breast cancer tnbc
36562461,chromosome instability disorders
36562461,"ovarian, pancreatic"
36561721,acute thrombocytopenia
36561074,photo-cytotoxicity
36560796,related diseases
36559700,cytotoxic
36559700,lung adenocarcinoma epithelial
36559330,cytotoxicity towards breast cancer
36559094,anti-breast cancer
36559029,musculoskeletal inflammation
36559029,inflammation of the joints
36559029,joints
36559029,tenosynovitis
36559029,musculoskeletal infiltrates
36558961,"pancreatic adenocarcinoma panc-1, melanoma a375, hepatocarcinoma"
36558953,p breast cancer
36558921,cancers of the pancreas
36558903,acidosis
36558554,hepatic carcinoma
36558554,loss of deltapsim
36558344,certain diseases like brain cancer
36557987,aggressive type of brain cancer
36557969,xrd
36557969,systemic toxicity
36557606,toxic shock syndrom
36556918,luminal a tumours
36556287,skin grafting in skin cancer-related facial reconstruction
36556287,non-melanoma skin cancer
36556287,facial cancer
36556274,breast infections
36556274,breast implant infection
36556228,systemic sclerosis
36556209,b breast cancer
36556185,inappropriate tumor
36556118,breast seromas aspiration
36556118,-breast-syndrome
36556118,abdominal hematoma
36556118,breast hematoma
36555890,blooms
36555256,skin and renal toxicity
36555137,renal and liver toxicity
36555137,cytotoxicity increased
36555129,bbb opening
36555124,psychological disorders
36555096,cytotoxicity of human breast cancer
36554776,macromastia/gigantomastia
36554776,macromastia
36554354,colonic neoplasms
36554354,cytomegalovirus infection
36553480,gastric carcinoma
36553148,breast-tumor stiffness
36553148,tumor stiffness
36553148,benign tumors
36553140,automatic breast cancer
36553140,neighborhood of the tumor
36553106,breast calcification
36553095,breast cancer digital
36553061,occult invasive serous carcinoma
36553061,serous tubal intraepithelial carcinoma
36553061,serous tubal intraepithelial lesion
36553004,hyperphosphatemia
36553004,albright hereditary osteodystrophy
36553004,hypocalcemia and hormone deficiencies
36553004,genetic defects
36552994,lung and ovarian cancer
36552958,malignancy of follicular neoplasms
36552748,kidney neoplasms
36552033,stomach carcinomas
36552021,type of metastatic disease
36551983,breast arterial calcifications
36551983,hypertensive heart disease
36551983,valvular heart disease
36551983,infarction
36551748,luminal-like breast cancer
36551742,breast cancer-brain metastasis
36551733,penile cancer
36551726,i-ii breast cancer
36551702,benign versus malignant breast lesions
36551693,breast primary tumor
36551684,her2-low tumor
36551681,"neighborhood education, inferior disease"
36551680,late toxicity
36551660,15 adsflt-infected tumors
36551660,adsflt-infected tumors
36551660,infected tumors
36551631,breast and pancreatic forms of cancer
36551631,melanoma malignum and pancreatic adenocarcinoma ranks
36551631,tumorous
36551605,breast cancer (bc)/ovarian cancer
36551601,pulmonary vein
36551573,female cancers
36551569,non-small cell lung carcinoma
36551567,intraoperative breast cancer metastasis
36551567,intraoperative breast cancer
36551566,hematologic neoplasms
36551566,soft tissue tumors
36551566,blood cancer
36551247,genetic abnormalities
36550858,fibrous tumor
36550858,solitary fibrous tumors
36550858,pleural sfts
36550858,myofibroblastoma
36550858,breast sfts
36550674,pilomatrix carcinoma
36550674,pilomatrixoma
36550674,pilomatric carcinoma
36550302,breast cancer tumours
36550258,low-income breast cancer
36550258,hrs
36550153,qnbc tumors
36549990,status in breast cancer brain metastases
36549600,her2-immunopositive breast cancer
36548597,alcoholic fatty liver disease
36548597,autistic disorder
36548597,myocardial ischemia
36548533,breast cancer cad systems
36548287,hereditary breast ovarian cancer syndrome
36548287,hboc
36548194,epcam positive tumors
36547420,"spirulina platensis, ganoderma lucidum"
36547220,cutaneous metastasis
36547220,cutaneous metastases
36547220,skin tumors
36547220,leukemic infiltrates
36547220,dermal sclerosis
36547201,primary non-small cell lung adenocarcinomas
36547201,ataxia-telangiectasia
36547201,autosomal recessive disorder
36547192,her2 positive breast cancer
36547170,abemaciclib plus letrozole
36547168,psyndexplus
36547148,49 lesions
36547062,ii invasive breast cancer
36546899,epcam monoclonal antibody
36546899,breast and pancreatic cancers
36546552,fatigue in breast cancer
36545949,tumor cell stemness
36545949,syngeneic oral cancer
36545721,catastrophic disorders
36545558,intravascular coagulation
36545507,crohn's disease
36545507,"pancreatic ductal carcinoma, ovarian cancer"
36545425,insufficient calcification
36545273,coronary atherosclerosis
36544779,pd-l1+ tumor
36544628,acute brain edema
36544523,increase tumor necrosis
36544182,ovarian or breast cancer
36544128,seroma aspirations
36544126,depression symptoms
36544021,ataxia oculomotor apraxia
36544021,neurodegeneration
36543994,declines in esophageal cancer
36543879,familial myeloproliferative neoplasms
36543879,myeloproliferative neoplasms
36543879,mpns
36543807,takayasu's arteritis
36543807,myelodysplasia
36543379,tumorous proliferation
36543377,anaphylaxis
36543377,renal renca tumor
36543349,malignant pleural effusions
36543349,thoracentesis changes across cancers
36543162,proteinuria
36543162,angina pectoris
36543102,breast cancer deaths
36543055,intraoperative hypothermia
36543055,hypothermic
36543055,hypothermia
36542825,tumor er ihc
36542647,long cancers
36542647,hypothetical multi-cancer
36542647,colon/rectum
36542580,osteonecrosis
36542580,bone-metabolic disorders
36542569,syringomatous adenoma
36542569,benign infiltrative neoplasm
36542569,bilateral invasive ductal carcinoma and ductal carcinoma
36542569,syringomatous adenomas
36542569,syringomatous carcinoma
36542569,tubular carcinoma
36542511,breast or prostate cancer
36542482,loss of invasiveness
36542473,impairments
36542180,goodness
36542157,se-hplc
36542138,subcutaneous emphysema
36542138,postoperative hypoparathyroidism
36542092,situ carcinomas
36541910,deficiency decreased
36541871,breast arterial calcification
36541716,malignant carcinoma
36541716,hypoxic conditions
36541716,hypoxic tumors
36541716,multiple tumors
36541514,brca1 haploinsufficiency impairs iron metabolism
36541514,mesothelioma via ferroptosis
36541514,malignant mesothelioma
36541514,mms brca1-haploinsufficient
36541484,actual tumors
36541460,glycerophospholipid metabolism
36541457,immunomodulation of the tumor
36540647,breast cancer delay
36540647,primary invasive breast cancer
36540494,primary malignant peripheral nerve sheath tumor
36540494,primary breast sarcomas
36540494,sheath tumors
36540494,neurofibromatosis type i
36540494,sheath tumor
36540467,colorectal adenocarcinomas
36540467,esophageal adenocarcinomas
36540467,respiratory infections
36540457,spontaneous angiolipoma
36540457,angiolipomas
36540457,benign lipomatous tumors
36540457,angiolipoma
36540444,synchronous breast cancer
36540444,pleural epithelioid mesothelioma
36540444,synchronous pleural mesothelioma
36540444,dyspnoea
36540444,synchronous malignancy
36540444,synchronous tumours
36540444,pleural mesothelioma
36540440,squamous cell skin cancer
36540407,mcf-7 carcinoma
36539956,pancreatic (mpc) cancer
36539956,stable disease
36539911,acute central scotoma
36539911,blurry vision
36539895,digital breast cancer
36539895,001 versus oncotype rs plus pdxbr
36539893,ataxia telangiectasia
36539890,juxta-tumor
36539890,juxta-tumors
36539766,language websites
36539766,persian language websites
36539745,cervical squamous cancer
36539745,iiib-iva disease
36539745,iiia-iva squamous cervical cancer
36539745,stage iib disease
36539745,synchronous treatment failure
36539745,died of the disease
36539745,hematological toxicities
36539672,her2-positive metastatic breast cancer
36539672,visceral disease
36539670,endocrine
36539586,colon cancer solid tumors
36539520,para-carcinoma
36539400,pancreatic ductal adenocarcinoma and breast cancer
36539400,metastasis of melanoma
36539250,primary small cell lung carcinoma
36539250,left breast cancer(invasive ductal carcinoma)in
36539241,luminal-type breast cancer
36539240,breast and endocrine tumor
36539231,pleural metastasis of breast cancer
36539231,lymph nodes swelling
36539231,pleural nodules
36539231,solid-tubular carcinoma
36539160,appetite sensations
36539160,sed
36539001,ptx-resistant breast cancer
36538894,quasi-mesenchymal cancer
36538894,quasi-mesenchymal cscs
36538867,vascular anastomosis
36538844,radiotoxicity
36538401,edematous upper limb
36538387,endometrial serous carcinoma and colorectal carcinoma
36538387,breast and gastroesophageal carcinoma
36538247,hiv infection
36538247,i-iii hr-positive breast cancer
36538110,pn symptoms
36538110,cognitive memory
36537914,increase tumor
36537740,embryonic kidney cell
36537474,neurologic complications of breast cancer
36537474,unique neurologic complications
36537474,cns disease
36537474,neurological complications
36537324,breast adenocarcinoma tumour
36537080,"epithelial ovarian, fallopian tube"
36537080,peritoneal cancers
36536938,carcinoma embryonic
36536772,learning-based ovarian cancer
36536772,dmmn-ovary
36536735,pelvic malignancy
36536719,breast cosmesis
36536539,lung squamous carcinoma
36536425,brca-negative breast cancer
36536421,ibs
36536266,muscle mass loss in breast cancer
36536198,ticd
36535720,invasive breast neoplasia
36535720,non-invasive breast neoplasia
36535720,situ neoplasia
36535655,prostatic
36535569,cardiac glycosides
36535556,melanoma cancer
36535490,immunodeficient tumour
36535221,hypoxia-responsive covalent organic
36535221,shock proteins
36535072,her2-zero breast cancer
36534783,breast defects
36534524,biopsy-breast cancer
36534331,aggressive human fibrosarcomas
36534241,malignancy of ads
36534173,financial hardship in breast cancer
36534108,precancerous lesions
36534098,oncoplastic-augmentation-mastopexy
36534097,breast radiation desiring breast reduction
36534097,mastopexies
36534085,cardiac inflammation
36533825,ovarian adenocarcinoma
36533725,intratumor aggregation
36533707,pten hamartoma tumor syndrome
36533707,type of breast disease
36533707,decreased tumor
36533572,her2-positive breast cancer brain metastasis
36533508,disabilities
36533448,ggms
36533448,basal-type breast cancer
36532885,mesothelioma tumor
36532833,stomach adenocarcinomas
36532833,gastrointestinal tumors
36532768,hifs in breast cancer
36532555,alzheimer
36532255,her2-low advanced breast cancer
36532066,efficiency of ovarian cancer
36532066,tumor immunogenic cell death
36531991,steatohepatitis
36531861,breast microtumors
36531806,weigh loss
36531539,lymphovascular emboli
36531523,financial toxicities
36531523,nonmelanoma/other skin cancer
36531496,type ii diabetes
36531496,metabolic disorder
36531496,dysfunctional breast tme
36531327,bone-metastasized breast cancer
36531239,microsatellite-instability-high cancers
36531239,microsatellite-instability-high (msi-h) cancers
36531239,lynch syndrome cancers
36531239,msi-h cancers
36531159,immune disorders
36531148,malignant breast neoplasms
36531115,mortal cancers
36531105,fit
36531080,modena cancer
36531080,multifocal disease
36531077,flushing interval
36531077,flushing
36531077,catheter obstruction
36531077,pump-back
36531067,cystic brain metastases
36531052,malignant breast lesion
36531035,invasive metastasis
36531035,breast breast cancer
36530984,retinoblastoma
36530852,microvascular anastomosis
36530474,chasmplus algorithm
36530255,breast and liver cancer
36530255,sec-cancer
36530069,hyperprolactinemia
36530069,hypperprolactinaemia
36529819,novel disorder
36529796,car-t
36529796,scfv cars
36529791,li-fraumeni-like syndrome
36529791,primary colon
36529791,bowel malignancies
36529779,cholestasis worsen pancreatic cancer
36529768,immunodeficiency virus and acquired immune deficiency syndrome
36529697,liver and brain metastases of breast cancer
36529697,breast cancer liver and brain metastases
36529686,pyroptosis-dominant breast cancer
36529603,her2-low versus her2-zero breast cancer
36528837,upper limb dysfunction
36528837,postoperative central sensitization
36528757,secondary tumours
36528757,intraocular cancer
36528757,glioblastoma and renal cell carcinoma
36528757,endometriosis cancer
36528757,retinoblastoma cancer
36528717,original breast cancer
36528621,breast neuroendocrine tumor
36528621,breast carcinomas of the axilla
36528621,primary breast neuroendocrine tumors
36528621,axillary lymph node swelling
36528568,mdd
36528568,high anxiety
36528449,vas pain
36528228,radiation related injury
36527994,prostate carcinoma
36527788,papillary thyroid carcinoma motility
36527722,deep-inspiration breath-hold
36527722,free-breath
36527702,nausea and vomiting
36527702,breakthrough cinv
36527648,nad(h) involvement
36527643,tumour nad(h
36527643,tumour nad
36527601,new breast cancer
36527534,osteoporotic fracture
36527534,fragility fractures
36527534,respiratory tract infection
36527534,osteoporotic fractures
36527520,cipn
36527520,ra
36527372,sclerosing adenosis of the prostate-a benign lesion
36527372,benign non-neoplastic small acinar hyperplasia
36527372,malignant lesions of the prostate
36527372,dysuria
36527372,benign lesion
36527253,hg-mbc
36527253,squamous
36526859,empathy
36526859,breast cancer stigma
36526827,breast and thyroid cancer
36526807,neighborhood deprivation
36526666,siesta
36526072,malaria
36526072,chorioamnionitis
36526044,tumour-localising photosensitiser
36526044,tumour damage
36526003,trypanosoma cruzi infection
36526003,cruzi infection
36525612,stage iv disease
36525564,drug-resistant breast cancers
36525564,alps
36525542,metaplastic carcinoma
36525542,urothelial carcinomas
36525542,cholangiocarcinomas
36525542,ovarian carcinomas
36525542,lung adenocarcinomas
36525542,invasive metaplastic carcinomas
36525230,omd
36525099,anxiety-depression
36525062,palsy
36525062,thyroid diseases
36524250,schizophrenia
36524250,attention-deficit hyperactivity disorder
36524129,hallmark of cancer
36524084,multiple diseases
36523985,aggressive ovarian cancer
36523985,drug-resistant ovarian cancer
36523985,behaviors of ovarian cancer
36523982,rhabdomyosarcoma
36523982,meningeal rhabdomyosarcoma
36523982,central memory
36523797,rotation error
36523671,familial cancer syndromes
36523671,endocrine tumors
36523671,multiple endocrine neoplasia syndrome
36523671,tumors of the syndrome
36523564,tumors across multiple cancer
36523564,tiny tumors
36523564,prostate plus liver and thyroid cancers
36523319,invasive breast ductal carcinoma
36523319,allergic constitution
36523215,inherited cancer
36523215,"hereditary breast, ovarian, colorectal and prostate cancers"
36523121,bilateral breast multiple myeloma
36522712,invasive ductal breast carcinoma
36522712,myocardial dysfunction
36522712,myocardial damage
36522712,lv contractility injury
36522683,metastasis of esophageal squamous cell carcinoma
36522683,tumor cell malignancy
36522673,muscle twitching
36522673,spasms
36522480,tumour suppression
36522227,immune thrombocytopenia
36521881,cancer benchmarking partnership
36521557,malignant cancers
36521553,hereditary syndrome
36521545,rhythm disorders
36521467,galactorrhea
36521467,breast milk
36521467,pituitary microadenomas
36521467,chronic renal failure
36521467,cirrhosis
36521467,pituitary macroadenomas
36521467,hypothalamic lesions
36521418,durvalumab plus tremelimumab
36521418,colitis
36521418,dry skin
36521418,hyperthyroidism
36521291,autoimmune symptoms
36521291,synchronous tumors
36521105,blood cancers
36521078,premenopausal breast cancer
36521078,ovarian function suppression
36521033,decreased neurotoxicity
36520383,tumor breast favor breast cancer
36520383,component of breast stroma
36520228,nh-black-rural
36520101,falling
36519609,invasive-ductal-carcinoma
36519609,progressive-disease
36519604,coagulation disorders
36519554,gastrointestinal and urogenital cancer
36519554,ovarian and bladder cancers
36519482,learning disabilities
36519225,adrenal incidentalomas
36518924,spinal metastasis
36518924,hematologic malignancy
36518924,gastrointestinal tumor
36518924,hematologic malignancy metastasis
36518756,rcd
36518691,"cholangiocarcinoma, ovarian cancer"
36518661,liver injury
36518661,acute respiratory distress syndrome
36518661,acute liver injury
36517957,peutz-jeghers syndrome
36517957,extra-gastrointestinal cancers
36517728,mood disturbances
36517728,sadness/depression
36517666,carcinogenic metabolites
36517577,luminal b breast cancer metastases in the eyes
36517577,breast cancer metastases in the eyes
36516931,wt
36516847,deficiency in luminal breast cancers
36516775,eralpha-positive breast cancer
36516681,good deformability
36516504,ptosis and breast hypertrophy
36516504,iii ptosis
36516498,vascular tumor
36515971,neoplastic cancer
36515971,head cancers
36515915,peritoneal carcinosis
36515915,lobular carcinomas
36515915,abdominal malignancies
36515701,radiation pneumonitis in breast cancer
36515701,radiation pneumonitis
36515701,lung toxicity
36515701,pneumonitis in breast cancer
36514668,disseminated peritoneal leiomyomatosis
36514641,oligometastatic spinal disease
36514641,spinal tumours
36514641,spinal disease
36514465,mental disorder
36514288,anaplastic epithelioid cell neoplasms
36514176,myxoid liposarcoma
36514176,pleomorphic liposarcoma
36514176,myxoid pleomorphic liposarcoma
36514176,liposarcomas
36514134,cancers beyond lymphohematopoietic cancer
36514122,cognition impairments
36514083,lewis lung carcinoma (llc-1) cancer
36513982,multidisciplinary sarcoma board
36513982,fatty tumors
36513955,alnd
36513917,hypercholesterolemia
36513914,chronic neck pain
36513914,neck pain
36513135,tnbc tumour
36513135,aggressive tnbc tumour
36513033,metastatic carcinoma
36513033,epithelial carcinoma
36513014,adms
36512648,endocrine malignancy
36512487,endometrial and cervical cancer
36512174,obstructive sleep apnoea
36512174,obstructive sleep apnea
36512174,apnealink air apnoea-hypopnea
36512157,postoperative complications of breast cancer
36512057,qfracture
36512057,hormone-responsive cancers
36512057,bone loss and fractures
36511578,colon cancers
36511380,non-thyroid cancer
36511380,non-melanoma skin
36511380,non-thyroid cancers
36511015,syndromic
36511015,thyroid carcinomas
36511011,thyroid follicular carcinoma
36511011,carcinoma of the thyroid
36511011,metastasis of thyroid follicular cancer
36510986,bilateral breast carcinoma
36510986,synchronous malignancies
36510985,deep inspiration breath-hold
36510985,bl
36510982,invasive ductal carcinoma of breast
36510887,lymphoid leukaemia
36510872,retroperitoneal metastasis of breast cancer
36510679,hdbc
36510679,hbd
36510636,gingival carcinoma hgf-1
36510636,gingival tumors
36510636,pinus densiflora leaf
36510636,gingival cancer
36510632,hysteromyoma and endometrial cancer
36510632,endometrial dysplasia
36510632,endometrial precancerous lesions
36510567,a cancer
36510562,osteogenic differentiation
36510562,"osteosarcoma, breast cancer"
36510497,thyroid papillary carcinoma
36510480,psychosocial distress
36510353,benign breast tumours and breast cancer
36510247,fetal trisomy anomaly
36510219,breast cancer launching
36510219,tumour invasion
